Welbilt (WBT) 10-Q 6 May 21 2021 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2021	May 03, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	1-37548
Entity Registrant Name	Welbilt, Inc.
Entity Central Index Key	0001650962
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4625716
Entity Address, Address Line One	2227 Welbilt Boulevard
Entity Address, City or Town	New Port Richey
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	34655
City Area Code	727
Local Phone Number	375-7010
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	WBT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		141,918,232

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net sales	$ 316.8	$ 328.9
Cost of sales	199	214.1
Gross profit	117.8	114.8
Selling, general and administrative expenses	76	86.5
Amortization expense	10.1	9.7
Restructuring and other expense	0.2	6.8
Loss from impairment and disposal of assets — net	0	11.2
Earnings from operations	31.5	0.6
Interest expense	18.7	22.4
Other expense (income) — net	3	(6.5)
Earnings (loss) before income taxes	9.8	(15.3)
Income tax expense (benefit)	1.9	(0.2)
Net loss	$ 7.9	$ (15.1)
Per share data:
Earnings (loss) per share — Basic (in dollars per share)	$ 0.06	$ (0.11)
Earnings (loss) per share — Diluted (in dollars per share)	$ 0.06	$ (0.11)
Weighted average shares outstanding — Basic (in shares)	141,622,281	141,430,614
Weighted average shares outstanding — Diluted (in shares)	142,189,112	141,430,614

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 7.9	$ (15.1)
Other comprehensive loss, net of tax:
Foreign currency translation adjustments	(7.1)	(28.2)
Unrealized loss on derivatives	(0.5)	(0.4)
Employee pension and postretirement benefits	0.4	2
Total other comprehensive loss, net of tax	(7.2)	(26.6)
Comprehensive income (loss)	$ 0.7	$ (41.7)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 140.3	$ 125
Restricted cash	0.5	0.4
Accounts receivable, less allowance of $4.4 and $4.4, respectively	174.5	165.9
Inventories — net	203.2	180.6
Prepaids and other current assets	49.9	50.1
Total current assets	568.4	522
Property, plant and equipment — net	129.6	129.1
Operating lease right-of-use assets	45.7	47.5
Goodwill	938.5	942.9
Other intangible assets — net	453.3	469.6
Other non-current assets	30	30.5
Total assets	2,165.5	2,141.6
Current liabilities:
Trade accounts payable	102.2	86.4
Accrued expenses and other liabilities	135.9	164.2
Current portion of long-term debt and finance leases	1.1	1
Product warranties	29.4	29.9
Total current liabilities	268.6	281.5
Long-term debt and finance leases	1,445.5	1,407.8
Deferred income taxes	74.9	76.5
Pension and postretirement health liabilities	25.3	27.8
Operating lease liabilities	36.5	37.7
Other long-term liabilities	37.1	37.3
Total non-current liabilities	1,619.3	1,587.1
Commitments and contingencies (Note 11)
Total equity:
Common stock ($0.01 par value, 300,000,000 shares authorized, 141,680,636 shares and 141,557,236 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively)	1.4	1.4
Additional paid-in capital (deficit)	(21.7)	(25.6)
Retained earnings	324.6	316.7
Accumulated other comprehensive loss	(26.7)	(19.5)
Total equity	277.6	273
Total liabilities and equity	$ 2,165.5	$ 2,141.6

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 4.4	$ 4.4
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	141,680,636	141,557,236
Common stock, outstanding (in shares)	141,680,636	141,557,236

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net earnings (loss)	$ 7.9	$ (15.1)
Adjustments to reconcile net earnings (loss) to cash used in operating activities:
Depreciation expense	5.4	5.2
Amortization of intangible assets	10.5	10
Amortization of debt issuance costs	1.3	1.1
Deferred income taxes	(0.2)	7
Stock-based compensation expense	3.2	1
Loss from impairment and disposal of assets — net	0	11.2
Changes in operating assets and liabilities:
Accounts receivable	(10.5)	(11.2)
Inventories	(23.7)	(19.1)
Other assets	2.2	(16.4)
Trade accounts payable	14.5	11.7
Other current and long-term liabilities	(27)	(57.9)
Net cash used in operating activities	(16.4)	(72.5)
Cash flows from investing activities
Capital expenditures	(4.7)	(5.6)
Other	0	(3.9)
Net cash used in investing activities	(4.7)	(9.5)
Cash flows from financing activities
Proceeds from long-term debt	58	128
Repayments on long-term debt and finance leases	(21.3)	(23.3)
Exercises of stock options	0.5	1.1
Payments on tax withholdings for equity awards	(0.1)	(0.7)
Net cash provided by financing activities	37.1	105.1
Effect of exchange rate changes on cash	(0.6)	(5.3)
Net increase in cash and cash equivalents and restricted cash	15.4	17.8
Balance at beginning of period	125.4	130.7
Balance at end of period	140.8	148.5
Supplemental disclosures of cash flow information:
Cash paid for income taxes, net of refunds	5.3	11.6
Cash paid for interest, net of related hedge settlements	27.6	31.4
Supplemental disclosures of non-cash activities:
Non-cash financing activity: Lease liabilities and assets obtained through leasing arrangements and reassessments and modifications of right-of-use assets	$ 1.6	$ 5.5

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions		Total		Cumulative effect of accounting standards adoption	[2]	Common Stock		Additional Paid-In Capital (Deficit)		Retained Earnings		Retained EarningsCumulative effect of accounting standards adoption	[2]	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019	[1]					141,213,995
Beginning balance at Dec. 31, 2019		$ 253.4	[1]	$ (0.4)		$ 1.4	[1]	$ (31)	[1]	$ 324.5	[1]	$ (0.4)		$ (41.5)	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)		(15.1)								(15.1)
Issuance of common stock, stock-based compensation plans (in shares)						273,532
Issuance of common stock, stock-based compensation plans		1.1						1.1
Stock-based compensation expense		1						1
Other comprehensive loss		(26.6)												(26.6)
Ending balance (in shares) at Mar. 31, 2020						141,487,527
Ending balance at Mar. 31, 2020		$ 213.4				$ 1.4		(28.9)		309				(68.1)
Beginning balance (in shares) at Dec. 31, 2020		141,557,236				141,557,236
Beginning balance at Dec. 31, 2020		$ 273				$ 1.4		(25.6)		316.7				(19.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)		7.9								7.9
Issuance of common stock, stock-based compensation plans (in shares)						123,400
Issuance of common stock, stock-based compensation plans		0.7						0.7
Stock-based compensation expense		3.2						3.2
Other comprehensive loss		$ (7.2)												(7.2)
Ending balance (in shares) at Mar. 31, 2021		141,680,636				141,680,636
Ending balance at Mar. 31, 2021		$ 277.6				$ 1.4		$ (21.7)		$ 324.6				$ (26.7)
[1]	(1) As of December 31, 2019, the Company reclassified a portion of the liability within the Welbilt Deferred Compensation Plan totaling $0.4 million from "Other long-term liabilities" to "Treasury stock" to properly net the liability with the corresponding Welbilt common stock owned by the Deferred Compensation Plan. See further discussion in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.
[2]	(2) Effective January 1, 2020, the Company adopted Accounting Standards Update ("ASU") 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," including subsequent amendments issued thereafter which clarify the standard (collectively, "Topic 326"). The cumulative effect of the change made to the Consolidated Statement of Equity as of January 1, 2020 for the adoption of ASU 2016-13 is the result of recognizing an additional expected credit loss allowance.

Statement of Shareholders' Equi

Statement of Shareholders' Equity (Parenthetical) $ in Millions	Dec. 31, 2019USD ($)
Adjustment | Treasury Stock
Deferred compensation liability	$ 0.4

Business and Organization

Business and Organization	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Business and Organization	Business and Organization Welbilt, Inc. ("Welbilt" or the "Company") is one of the world’s leading commercial foodservice equipment companies leveraging a full suite of equipment capable of storing, cooking, holding, displaying, dispensing and serving in both hot and cold foodservice categories. The Company is headquartered in New Port Richey, Florida, and operates 19 manufacturing facilities globally. The Company designs, manufactures and supplies best-in-class equipment for the global commercial foodservice market, consisting of commercial and institutional foodservice operators represented by full-service restaurants, quick-service restaurant chains, hotels, resorts, cruise ships, caterers, supermarkets, convenience stores, hospitals, schools and other institutions. The Company sells its products through a global network of over 5,000 distributors, dealers, buying groups and manufacturers' representatives. Welbilt was incorporated in Delaware in 2015 and became publicly traded in March 2016 under the New York Stock Exchange ("NYSE") ticker symbol "MFS" after the Company completed its spin-off from The Manitowoc Company, Inc. ("MTW") (the "Spin-Off"). On March 6, 2017, shares of the Company commenced trading under a new NYSE ticker symbol, "WBT" when the Company effected its name change from "Manitowoc Foodservice, Inc." to "Welbilt, Inc." The Company manages its business in three geographic business segments: Americas, EMEA and APAC. The Americas segment includes the United States ("U.S."), Canada and Latin America. The EMEA segment consists of markets in Europe, including Middle East, Russia, Africa and the Commonwealth of Independent States. The APAC segment consists primarily of markets in China, India, Australia, South Korea, Singapore, Philippines, Japan, Indonesia, Malaysia, Thailand, Hong Kong, Taiwan, New Zealand and Vietnam.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Principles of Consolidation and Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of Welbilt and its wholly-owned subsidiaries and have been prepared by the Company, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). The Company prepares its financial statements in accordance with accounting principles generally accepted in the U.S. ("U.S. GAAP"). All intercompany balances and transactions between the Company and its affiliates have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include inventory obsolescence costs, warranty costs, product liability costs, employee benefit programs, sales rebates and the measurement of income tax assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates. The ongoing COVID-19 pandemic has created and may continue to create significant uncertainty in the macroeconomic environment which, in addition to other unforeseen effects of this pandemic, may adversely impact the Company's future operating results. As a result, many of the Company's estimates and assumptions may require increased judgment and involve a higher degree of variability and volatility. As the impacts of the pandemic continue to evolve and additional information becomes available, these estimates may change materially in future periods. In the opinion of management, the consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations and comprehensive income (loss) for the three months ended March 31, 2021 and 2020, the financial position as of March 31, 2021 and December 31, 2020 and the cash flows for the three months ended March 31, 2021 and 2020, and except as otherwise discussed herein, such adjustments consist only of those of a normal recurring nature. The interim results are not necessarily indicative of results that may be achieved in a full reporting year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the SEC rules and regulations governing interim financial statements. However, the Company believes that the disclosures made in the unaudited consolidated financial statements and related notes are adequate to make the information presented not misleading. These consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020. All dollar amounts, except share and per share amounts, are in millions of dollars unless otherwise indicated. Government Assistance The Company's policy for government assistance is to recognize the assistance when there is reasonable assurance that the Company has met the substantive conditions of and requirements for receiving the assistance. The government assistance is recorded as a reduction to the related expense to which the assistance relates. Beginning in the second quarter of 2020, as a result of the COVID-19 pandemic, governments in various jurisdictions in which the Company operates have provided financial assistance designed to offset salary expenditures associated with companies maintaining their pre-pandemic employee headcount levels. The Company has applied and will continue to apply for such assistance programs where relevant requirements and conditions have been met. For the three months ended March 31, 2021, the Company met the requirements to receive $1.8 million of government assistance in the form of cash, cost abatements and retention credits. As of March 31, 2021, the Company has a receivable for $1.9 million related to government assistance. No government assistance was received during the quarter ended March 31, 2020. Government assistance has been reflected as a reduction to the related expense for which the assistance relates as follows: (in millions) Three Months Ended March 31, 2021 Reduction to related expense (1) : Cost of sales $ 0.4 Selling, general and administrative expenses 0.8 Total $ 1.2 As of March 31, 2021 and December 31, 2020, $0.6 million and $1.9 million, respectively, of government assistance was included as a reduction in capitalized labor, and is included as a component of "Inventories — net". This portion of government assistance will be recognized as a reduction to "Cost of sales" when the associated inventory is sold. Recently Adopted Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04") to provide temporary optional expedients and exceptions to U.S. GAAP guidance on contract modifications, hedge accounting and other transactions affected by the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. ASU 2020-04 is effective upon issuance and the Company may elect to apply the standard through December 31, 2022. This guidance primarily impacts the interest expense under the Company's 2016 Credit Facility which utilizes LIBOR as a basis. As the Company has not executed a modification of the interest component of this financial instrument and does not have related outstanding hedges in place as of March 31, 2021, the guidance has not impacted the Company's consolidated financial statements to date. The Company will evaluate the impact of adopting this guidance at the time such transition to an alternative reference rate occurs. In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" ("ASU 2019-12"), which amends, and is intended to simplify, existing guidance related to the accounting for income taxes. ASU 2019-12 was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted ASU 2019-12 prospectively as of January 1, 2021 which did not have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact on the Company.

Inventories - Net

Inventories - Net	3 Months Ended
	Mar. 31, 2021
Inventory Disclosure [Abstract]
Inventories - Net	Inventories — Net The components of "Inventories — net" are as follows: (in millions) March 31, December 31, 2021 2020 Inventories — net: Raw materials $ 92.5 $ 85.6 Work-in-process 14.9 13.9 Finished goods 100.1 85.4 Total inventories at FIFO cost 207.5 184.9 LIFO Reserve (4.3) (4.3) Total inventories — net $ 203.2 $ 180.6

Property, Plant and Equipment -

Property, Plant and Equipment - Net	3 Months Ended
	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment - Net	Property, Plant and Equipment — Net The components of "Property, plant and equipment — net" are as follows: (in millions) March 31, December 31, 2021 2020 Property, plant and equipment — net: Land $ 9.7 $ 9.7 Building and improvements 100.6 99.8 Machinery, equipment and tooling 231.2 231.7 Furniture and fixtures 8.1 8.1 Computer hardware and software for internal use 67.6 66.8 Construction in progress 13.2 14.1 Total cost 430.4 430.2 Less accumulated depreciation (300.8) (301.1) Total property, plant and equipment — net $ 129.6 $ 129.1

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets - Net	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets - Net	Goodwill and Other Intangible Assets — Net The Company's annual impairment tests of goodwill and intangible assets with indefinite lives are performed as of June 30 of each fiscal year and whenever a triggering event occurs between annual impairment tests. The Company's trademarks and tradenames are classified as indefinite-lived intangible assets as there are no regulatory, contractual, competitive, economic or other factors which limit the useful lives of these intangible assets. The indefinite-lived intangible asset impairment test is performed at the Company's unit of account level, which is the Americas, EMEA and APAC. The goodwill impairment test is performed for the Company's reporting units, which are the Americas, EMEA and APAC. During the first quarter of 2020, as a result of the decrease in demand for commercial foodservice equipment and aftermarket parts resulting from the COVID-19 pandemic and impacts on the Company's current and estimated future operating cash flows, management performed a review of the Company's goodwill and indefinite-lived intangible assets to determine whether it was more-likely-than-not that the fair value of such assets was less than their carrying amount as of March 31, 2020. This review included the Company's evaluation of relevant events and circumstances in totality that affect the fair value of the reporting units or indefinite-lived intangible assets. These events and circumstances include, but are not limited to, macroeconomic conditions (including the impact of COVID-19), industry and competitive environment conditions, overall financial performance, business specific events and market considerations. Management's review concluded for each of its reporting units and for the Americas indefinite-lived intangible assets that it is not more-likely-than-not that the fair value is less than the carrying amount based on the preponderance of evidence. Therefore, no impairment was indicated and no impairment test was required to be performed as of March 31, 2020. However, for both the EMEA and APAC indefinite-lived intangible assets, the review indicated, based on limited fair value cushion and overall financial performance expectations, that it is more-likely-than-not that the fair value of the indefinite-lived intangible assets is less than the carrying amount and, therefore, a quantitative impairment test was performed as of March 31, 2020. The Company estimated the fair value of the EMEA and APAC indefinite-lived intangible assets which were then compared to the carrying values of the relevant indefinite-lived intangible asset and to the extent the carrying value exceeded the estimated fair value, an impairment loss was recognized in the amount by which the carrying amount of the asset exceeded the estimated fair value of the asset. As of March 31, 2020, the Company determined that the carrying value of the indefinite-lived intangible assets in the EMEA region exceeded their estimated fair value and as a result, an impairment charge of $11.1 million was recorded for the first quarter of 2020. This impairment charge has been reflected as a component of "Loss from impairment and disposal of assets — net" for the three months ended March 31, 2020. Management determined that the fair value of the indefinite-lived intangible assets in the APAC region exceeded the carrying value of these assets and, therefore, concluded there was no impairment of these assets as of March 31, 2020. There were no further impairments of the Company's indefinite lived intangible assets during the remainder of the year ended December 31, 2020. In addition, there were no triggering events identified by the Company during the first quarter of 2021 which would require management to perform an impairment test. In management’s opinion, the indefinite-lived intangible assets in the EMEA region could be at risk of impairment in the near term if there is a negative change in the future financial performance of the EMEA region. As of both December 31, 2020 and March 31, 2021, the carrying value of the indefinite-lived intangible assets in the EMEA region approximated the fair value as a result of the impairment charge recorded during the first quarter of 2020, as discussed above. The duration and severity of the COVID-19 pandemic or other industry or competitive changes could result in future impairment charges to the Company's goodwill and remaining indefinite-lived intangible assets. Despite management's implemented strategies to address these events, a prolonged or more pronounced effect of the COVID-19 pandemic could negatively impact the results of operations and future financial performance expectations, resulting in changes in operating plans, or cause other adverse changes in the business, the foodservice industry or the macroeconomic environment, such as interest rate changes, that could trigger an impairment in the future. The changes in the carrying amount of goodwill by geographic business segment are as follows: (in millions) Americas EMEA APAC Total Goodwill balance at December 31, 2020 (1) $ 832.6 $ 89.3 $ 21.0 $ 942.9 Foreign currency impact — (4.3) (0.1) (4.4) Goodwill balance at March 31, 2021 $ 832.6 $ 85.0 $ 20.9 $ 938.5 (1) Goodwill is net of accumulated impairment losses of $515.7 million: $312.2 million recorded for the Americas and $203.5 million recorded for EMEA, both of which were recorded prior to December 31, 2018. The gross carrying amounts, impairment charges and accumulated amortization of the Company's intangible assets, other than goodwill, are as follows: (in millions) March 31, 2021 December 31, 2020 Gross Accumulated Net Gross Impairment Charges Accumulated Net Customer relationships $ 476.4 $ (277.5) $ 198.9 $ 479.1 $ — $ (271.6) $ 207.5 Trademarks and trade names 209.2 (0.2) 209.0 223.1 (11.1) — 212.0 Other intangibles 170.7 (128.8) 41.9 173.1 — (126.6) 46.5 Patents 5.8 (2.3) 3.5 5.8 — (2.2) 3.6 Total $ 862.1 $ (408.8) $ 453.3 $ 881.1 $ (11.1) $ (400.4) $ 469.6 As of March 31, 2021, trademarks and trade names by business segment are: $130.6 million in the Americas, $70.8 million in EMEA and $7.6 million in APAC. As of December 31, 2020, trademarks and trade names by business segment are: $130.6 million in the Americas, $73.6 million in EMEA and $7.8 million in APAC.

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	3 Months Ended
	Mar. 31, 2021
Payables and Accruals [Abstract]
Accrued Expenses and Other Liabilities	Accrued Expenses and Other Liabilities The components of "Accrued expenses and other liabilities" are as follows: (in millions) March 31, December 31, 2021 2020 Accrued expenses and other liabilities: Miscellaneous accrued expenses $ 38.5 $ 37.5 Employee related expenses 32.6 35.6 Accrued rebates and commissions 28.3 40.1 Current portion of operating lease liabilities 9.3 9.7 Interest payable 6.0 16.1 Customer deposits 5.0 3.9 Non-income taxes payable 3.6 3.6 Restructuring liabilities 3.2 4.0 Deferred revenues 2.9 2.9 Pension and postretirement health liabilities 2.1 2.1 Business Transformation Program related expenses 1.5 0.8 Product liabilities 1.5 1.7 Income and other taxes payable 1.0 5.6 Derivative liabilities 0.4 0.6 Total accrued expenses and other liabilities $ 135.9 $ 164.2

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was enacted on March 27, 2020 and includes many measures intended to assist companies during the COVID-19 pandemic including temporary changes to income and non-income-based tax laws, some of which were enacted under the Tax Cuts and Jobs Act ("Tax Act") in 2017. As a result of the Tax Act and the CARES Act, additional legislative and regulatory guidance has been and may continue to be issued, including final regulations that could impact the Company's effective tax rate in future periods. For the three months ended March 31, 2021, the Company recorded a $1.9 million income tax expense, reflecting a 19.4% effective tax rate, compared to a $0.2 million income tax benefit for the three months ended March 31, 2020, reflecting a 1.3% effective tax rate. The change in the effective tax rate for the three months ended March 31, 2021 compared to the same period of the prior year is primarily the result of the Company's increase in earnings before income taxes and changes in discrete tax items as a result of the change in uncertain tax positions, CARES Act net operating loss carryback provisions enacted in 2020 and the relative weighting of jurisdictional income and loss. For the three months ended March 31, 2021, the income tax provision is primarily the result of the relative weighting of jurisdictional income and loss. The Company’s effective tax rate for the three months ended March 31, 2021 and March 31, 2020 varies from the 21.0% U.S. federal statutory rate primarily due to the relative weighting of foreign earnings before income taxes, discrete tax items and taxes on foreign income. The Company’s 1.3% effective tax rate for the three months ended March 31, 2020 also included net discrete expenses of $4.6 million primarily related to the CARES Act legislation, including changes allowing for net operating loss carryback. Foreign earnings are generated from operations in all of the Company’s three geographic segments, Americas, EMEA and APAC. As of each reporting date, the Company’s management considers new evidence, both positive and negative, that could impact management’s view regarding the future realization of deferred tax assets. The Company will continue to evaluate its valuation allowance requirements, including the U.S. interest expense limitation of the Tax Act. As of March 31, 2021, the Company has determined that a valuation allowance is not required for the deferred tax asset associated with U.S. interest expense. The Company may adjust its deferred tax asset valuation allowances based on possible sources of taxable income that may be available to realize a tax benefit for deferred tax assets. As facts and circumstances change, the Company may also adjust its deferred tax asset valuation allowances accordingly. Such changes in the deferred tax asset valuation allowances would be reflected in current operations through the Company’s income tax provision and could have a material effect on the Company’s operating results for the respective period. The Company's unrecognized tax benefits, including interest and penalties, were $9.8 million and $9.9 million as of March 31, 2021, and December 31, 2020, respectively. During the next twelve months, it is reasonably possible that unrecognized tax benefits could change in the range of $1.6 million to $2.0 million due to the expiration of relevant statutes of limitations and federal, state and foreign tax audit resolutions. As of March 31, 2021 and December 31, 2020, the Company's Consolidated Balance Sheets includes $27.1 million and $27.4 million, respectively, of income tax receivables, classified within "Prepaids and other current assets." The Company files tax returns in multiple jurisdictions and is subject to examination by taxing authorities globally. The Company regularly assesses the likelihood of an adverse outcome resulting from examinations to determine the adequacy of its income tax reserves. As of March 31, 2021, the Company believes that it is more-likely-than-not that the tax positions it has taken will be sustained upon the resolution of its audits, resulting in no material impact on its consolidated financial position, results of operations and cash flows. However, the final determination with respect to any tax audits, and any related litigation, could be materially different from the Company's estimates and/or from its historical income tax provisions and accruals and could have a material effect on operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties and/or interest assessments. The Company is currently under audit by the tax authorities in Germany for the years 2015-2018 and in the U.S. for the 2017 and 2018 federal income tax returns, as well as various other state income tax and jurisdictional audits. The Company's federal and state income tax returns for tax years 2017 through 2019, and 2016 through 2019, respectively, remain subject to examination by U.S. federal and various state taxing authorities. Generally, the tax years 2016 through 2020 remain subject to examination in Canada, tax years 2015 through 2020 remain subject to examination in Germany, and tax years 2010 through 2020 remain subject to examination in China. As of March 31, 2021, the Company intends to continue reinvesting foreign earnings indefinitely outside of the U.S. with certain limited exceptions, and has not recorded a deferred tax liability for U.S. state income taxes, foreign withholding or other foreign income taxes that would be due if cash is repatriated to the U.S. because those foreign earnings are considered permanently reinvested or may be remitted substantially free of any additional income or withholding taxes. While the Company does not anticipate a need to repatriate funds to the U.S. to satisfy domestic liquidity needs, management reviews cash positions regularly and, to the extent it is determined that all or a portion of foreign earnings will not remain indefinitely reinvested, the Company will record a liability for the additional taxes, if applicable, including foreign withholding taxes and U.S. state income taxes. Further, the determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable.

Debt

Debt	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Debt	Debt The carrying value of the Company's outstanding debt consists of the following: (in millions, except percentage data) March 31, 2021 December 31, 2020 Carrying Value Weighted Average Interest Rate Carrying Value Weighted Average Interest Rate Long-term debt and finance leases: Revolving Credit Facility $ 180.0 4.44 % $ 143.0 4.21 % Term Loan B Facility 855.0 2.96 % 855.0 3.45 % 9.50% Senior Notes due 2024 425.0 9.72 % 425.0 9.72 % Finance leases 2.0 4.63 % 2.2 4.80 % Total debt and finance leases, including current portion 1,462.0 1,425.2 Less current portion: Finance leases (1.1) (1.0) Unamortized debt issuance costs (1) (15.7) (16.7) Hedge accounting fair value adjustment (2) 0.3 0.3 Total long-term debt and finance leases $ 1,445.5 $ 1,407.8 Total debt issuance costs, net of amortization as of March 31, 2021 and December 31, 2020, were $19.0 million and $20.3 million, respectively, of which $3.3 million and $3.6 million, respectively, are related to the Revolving Credit Facility and recorded in "Other non-current assets" in the Consolidated Balance Sheets. As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, amortization of debt issuance costs previously included as a component of "Other expense (income) — net" totaled $1.1 million for the three months ended March 31, 2020 and has been reclassified to include as a component of "Interest expense" in the Company's Consolidated Statements of Operations. (2) Balance represents deferred gains from the terminations of interest rate swaps designated as fair value hedges. In March 2016, the Company entered into a credit agreement, as amended, restated, supplemented or otherwise modified from time to time (the "2016 Credit Agreement") for a $1,300.0 million Senior Secured Credit Facility (the "Senior Secured Credit Facility") consisting of (i) a senior secured Term Loan B facility in an aggregate principal amount of $900.0 million (the "Term Loan B Facility") and (ii) a senior secured revolving credit facility in an aggregate principal amount of $400.0 million (the "Revolving Credit Facility"). The 2016 Credit Agreement also provides for a (i) sublimit for the issuance of letters of credit under the revolving commitments up to $30.0 million and (ii) aggregate principal amount of allowed incremental revolving or term loan facilities thereunder in an amount not to exceed the sum of (a) $275.0 million plus (b) an additional amount, as long as after giving effect to the incurrence of such additional amount, the proforma secured leverage ratio does not exceed 3.75:1.00. The maturity of the Term Loan B Facility and Revolving Credit Facility is October 2025 and October 2023, respectively. Each of the terms above were applicable with the latest amendment completed in April 2020, as further discussed below. The 2016 Credit Agreement contains financial covenants including, but not limited to (a) a Consolidated Interest Coverage Ratio, which measures the ratio of (i) Consolidated EBITDA to (ii) Consolidated Interest Expense, and (b) a Consolidated Total Leverage Ratio, which measures the ratio of (i) Consolidated Indebtedness to (ii) Consolidated EBITDA for the most recent four fiscal quarters, in each case, as defined in the 2016 Credit Agreement. In April 2020, the Company entered into Amendment No. 7 (“Amendment No.7”) to the 2016 Credit Agreement, to amend the financial covenants of the Revolving Credit Facility to prevent non-compliance with these financial covenants for the quarter ended June 30, 2020 resulting from the impact of the COVID-19 pandemic on the commercial foodservice industry and the resulting decrease in demand for the Company's products. The terms of Amendment No.7, among other items, (i) suspend the Consolidated Total Leverage Ratio and Consolidated Interest Coverage Ratio covenants, in each case, as defined in the 2016 Credit Agreement, for four fiscal quarters until March 31, 2021 ("Suspension Period") and (ii) temporarily replace the suspended covenants with a Minimum Consolidated EBITDA covenant and a Maximum Capital Expenditure covenant, each computed on a trailing four quarters basis and measured quarterly, and a Minimum Liquidity covenant that is measured monthly, each as defined in the Amendment, throughout the Suspension Period, with the Minimum Liquidity covenant extending through June 30, 2021. Beginning in the second quarter of 2020, the spreads for LIBOR and alternate base rate borrowings for the Revolving Credit Facility were 2.50% and 1.50%, respectively, as a result of the Company's Consolidated Total Leverage Ratio as of March 31, 2020. Beginning in the second quarter of 2021, the Consolidated Total Leverage Ratio and Consolidated Interest Coverage Ratio covenants will be reinstated at modified levels as compared to the covenants in effect as of June 30, 2020 and will return to the March 31, 2020 covenant levels by the fourth quarter of 2021. Amendment No.7 prohibits draws under the Revolving Credit Facility (i) if the Company has not evidenced compliance with the financial covenants for the year ending December 31, 2021 by delivery of a compliance certificate within 90 days, and (ii) to the extent the draw would result in a consolidated cash balance of $100.0 million or greater (excluding cash held in China) through December 31, 2021, with the exception of draws to meet cash uses anticipated in the ordinary course of business that are expected to be paid within 10 days of the draw. Amendment No.7 also includes additional limitations on restricted payments, investments and other actions that are otherwise allowed under the 2016 Credit Agreement, with a $25.0 million carve-out for general investments. These limitations expire on December 31, 2021. Amendment No.7 also includes a quarterly fee applicable through the fourth quarter of 2021 in an amount equal to a per annum rate of 0.50% on the average outstanding balance of the Revolving Credit Facility payable on a quarterly basis. The Company incurred total debt issuance costs in connection with Amendment No. 7 of $2.1 million, which were capitalized and included as a component of "Other non-current assets" on the Company's Consolidated Balance Sheets and will be amortized through the maturity of the Revolving Credit Facility. As of March 31, 2021, the Company had $6.6 million in outstanding stand-by letters of credit and $213.4 million available for additional borrowings under the Revolving Credit Facility, to the extent the Company's compliance with financial covenants permits such borrowings. As of March 31, 2021, the Company also had $1.3 million in other outstanding letters of credit or guarantees of payment to certain third-parties in accordance with commercial terms and conditions which did not reduce the amount available for additional borrowings under the Revolving Credit Facility. As of March 31, 2021, the Company was in compliance with all affirmative and negative covenants, including any financial covenants, pertaining to its financing arrangements. The Company continually monitors its compliance with the covenants in its Revolving Credit Facility, and in doing so has made estimates of the negative impact of the COVID-19 pandemic on its financial position, results of operations and cash flows. The Company believes it will remain in compliance with all such covenants for the next 12 months; however, due to the inherent uncertainty of the severity and duration of the COVID-19 pandemic on the Company's business, management's estimates of the achievement of its financial covenants may change in the future.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company's risk management objective is to ensure that business exposures to risks that have been identified and measured and are capable of being controlled are minimized or managed using what the Company believes to be the most effective and efficient methods to eliminate, reduce or transfer such exposures. Operating decisions consider these associated risks and the Company structures transactions to minimize or manage these risks whenever possible. The primary risks the Company manages using derivative instruments are interest rate risk, commodity price risk and foreign currency exchange risk. The Company enters into interest rate swap agreements to manage interest rate risk associated with the Company’s fixed and floating-rate borrowings. Cross-currency interest rate swaps are entered into to protect the value of the Company’s investments in its foreign subsidiaries. Swap contracts on various commodities are used to manage the price risk associated with forecasted purchases of materials used in the Company's manufacturing process. The Company also enters into various foreign currency derivative instruments to manage foreign currency risk associated with its projected purchases and sales and foreign currency denominated receivable and payable balances. The Company recognizes all derivative instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets. Commodity swaps and foreign currency exchange contracts are designated as cash flow hedges of forecasted purchases of commodities and currencies, certain interest rate swaps are designated as cash flow hedges of floating-rate borrowings, and the remainder of the instruments are designated as fair value hedges of fixed-rate borrowings and a cross-currency interest rate swap as a hedge of net investments in its foreign subsidiaries. Cash flow hedging strategy For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Loss "(AOCI") in the Company's Consolidated Balance Sheets and is subsequently reclassified into earnings in the periods in which the hedged transaction affects earnings. During the next twelve months, the Company estimates $0.4 million of unrealized gains, net of tax, related to currency rate and commodity price hedging will be reclassified from AOCI into earnings. Foreign currency and commodity hedging, prior to de-designation, is generally completed prospectively on a rolling basis for 15 and 36 months, respectively, depending on the type of risk being hedged. Prior to 2020, the Company entered into interest rate swap agreements to manage interest rate risk exposure by converting the Company’s floating-rate debt to a fixed-rate basis, thus reducing the impact from fluctuations in interest rates on future interest expense. These interest rate swap agreements involved the receipt of floating rate amounts in exchange for fixed rate interest payments over the life of the agreements without an exchange of the underlying principal. The remaining interest rate swap agreement with a notional amount of $425.0 million matured in the first quarter of 2020. The outstanding currency forward contracts which were entered into as hedges of forecasted transactions and continue to qualify for hedge accounting are as follows: Currency (in millions) Units Hedged March 31, December 31, 2021 2020 Canadian Dollar 9.2 6.4 Euro 5.1 3.3 British Pound 3.2 6.1 Mexican Peso 92.4 92.8 Singapore Dollar 2.3 2.3 The effects of the Company's derivative instruments on the Consolidated Statements of Comprehensive Income (Loss) and Consolidated Statements of Operations for gains or losses initially recognized in AOCI in the Consolidated Balance Sheets were as follows: Derivatives in cash flow hedging relationships Pretax gain/(loss) recognized in AOCI Pretax gain/(loss) reclassified from AOCI into income (in millions) Three Months Ended March 31, Location Three Months Ended March 31, 2021 2020 2021 2020 Foreign currency exchange contracts $ (0.2) $ (1.1) Cost of sales $ 0.4 $ (0.1) Commodity contracts — — Cost of sales — (0.5) Total $ (0.2) $ (1.1) $ 0.4 $ (0.6) Fair value hedging strategy For derivative instruments that qualify and are designated as a fair value hedge (i.e. hedging the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), the gain or loss on the derivative instrument as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in the same line item associated with the hedged item in the Company's Consolidated Statements of Operations. Effect of Fair Value and Cash Flow Derivative Instruments on Consolidated Statements of Operations The table below presents the effect of the Company’s derivative financial instruments on the Consolidated Statements of Operations: (in millions) Location and amount of gain/(loss) recognized on effect of fair value and cash flow derivative instruments Three Months Ended Three Months Ended March 31, 2021 March 31, 2020 Cost of Sales Interest Expense Cost of Sales Interest Expense Total amounts of expense line items presented in the Consolidated Statements of Operations in which effects of fair value and cash flow hedges are recorded $ 199.0 $ 18.7 $ 214.1 $ 22.4 The effects of fair value and cash flow hedging: Gain/(loss) on fair value hedging relationship: Interest rate contract: Hedged item $ — $ — $ — $ 0.1 Gain/(loss) on cash flow hedging relationships: Foreign currency exchange contracts: Amount of gain/(loss) reclassified from AOCI into income $ 0.4 $ — $ (0.1) $ — Commodity contracts: Amount of gain/(loss) reclassified from AOCI into income $ — $ — $ (0.5) $ — Hedge of net investment in foreign operations strategy For derivative instruments that qualify and are designated as a hedge of a net investment in a foreign currency, the gain or loss is reported in AOCI as a component of the cumulative translation adjustment. Amounts are reclassified out of AOCI into earnings when the hedged net investment is either sold or substantially liquidated. In March 2017, the Company entered into a three-year cross-currency interest rate swap contract ("CCS") for a notional value of €50.0 million to protect the value of its net investment in Euros. Prior to the expiration of the CCS in March 2020, the carrying value of the net investment in Euros was designated as a hedging instrument and remeasured at each reporting date to reflect the changes in the foreign currency exchange spot rate, with changes since the last remeasurement date recorded in AOCI. Upon expiration of the CCS in March 2020, the Company paid $4.1 million representing the final notional exchange at the expiration date spot exchange rate, which has been classified as an investing activity in the Company's Consolidated Statements of Cash Flows. The location and effects of the net investment hedge on the Consolidated Statements of Comprehensive Income (Loss) and Consolidated Statements of Operations are as follows: Derivative in net investment hedging relationship Pretax gain/(loss) recognized in AOCI Gain/(loss) reclassified from AOCI into income Gain/(loss) recognized in income (amount excluded from effectiveness testing) (in millions) Three Months Ended Location Three Months Ended Location Three Months Ended March 31, March 31, March 31, 2021 2020 2021 2020 2021 2020 Interest rate swap contract $ — $ (0.8) N/A $ — $ — Other expense (income) — net $ — $ 0.3 N/A = Not applicable Derivatives Not Designated as Hedging Instruments The Company enters into commodity and foreign currency exchange contracts that are not designated as hedge relationships to offset, in part, the impact of certain intercompany transactions and to further mitigate certain other short-term commodity and currency impacts, as identified. For derivative instruments that are not designated as hedging instruments, the gains or losses on the derivatives are recognized in current earnings within "Other expense (income) — net" in the Consolidated Statements of Operations. As of March 31, 2021, the Company had no outstanding commodity contracts which were not designated as hedging instruments. As of December 31, 2020, the Company had 35 and 18 metric tons of aluminum and copper, respectively, in outstanding commodity contracts that were not designated as hedging instruments. The Company also had the following outstanding currency forward contracts that were not designated as hedging instruments: Currency (in millions) Contracted Units March 31, December 31, 2021 2020 Canadian Dollar 1.8 1.1 Euro 82.7 84.2 Swiss Franc 7.0 7.0 British Pound 22.5 1.0 Singapore Dollar 0.6 0.3 Mexican Peso 20.9 13.8 For the three months ended March 31, 2021 and March 31, 2020, the Company recognized an expense of $2.5 million and income of $2.0 million, respectively, related to foreign currency exchange contracts. For the three months ended March 31, 2020, the Company also recognized income of $0.5 million related to commodity contracts. The gains and losses related to derivative instruments not designated as hedging instruments are included in Other expense (income) — net in the Company's Consolidated Statements of Operations. The fair value of outstanding derivative contracts recorded as assets in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Asset Derivatives March 31, December 31, 2021 2020 Derivatives designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ 0.6 $ 1.1 Total derivatives designated as hedging instruments $ 0.6 $ 1.1 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ 0.7 $ 0.9 Total derivatives NOT designated as hedging instruments $ 0.7 $ 0.9 Total asset derivatives $ 1.3 $ 2.0 The fair value of outstanding derivative contracts recorded as liabilities in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Liability Derivatives March 31, December 31, 2021 2020 Derivatives designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.2 $ 0.2 Total derivatives designated as hedging instruments $ 0.2 $ 0.2 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.2 $ 0.4 Total derivatives NOT designated as hedging instruments $ 0.2 $ 0.4 Total liability derivatives $ 0.4 $ 0.6

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments In accordance with the Company's policy, fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The policy classifies the inputs used to measure fair value into the following hierarchy: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 Unadjusted quoted prices in active markets for similar assets or liabilities, or Level 3 Unobservable inputs for the asset or liability Interim Disclosures About Fair Value of Financial Instruments The Company utilizes the best available information in measuring fair value. The carrying values of cash, restricted cash and cash equivalents, accounts receivable and trade accounts payable approximate fair value, without being discounted, as of March 31, 2021 and December 31, 2020, due to the short-term nature of these instruments. The Company's Revolving Credit Facility, Term Loan B Facility and Senior Notes are recorded at their carrying values on the Company's Consolidated Balance Sheets, as disclosed in Note 8, "Debt." The carrying value of the Revolving Credit Facility approximates its fair value due to the short-term variable interest rates of the borrowings. The Company estimates the fair value of the Term Loan B Facility and the Senior Notes based on quoted market prices of the instruments. Because these instruments are typically thinly traded, the assets and liabilities are classified as Level 2 of the fair value hierarchy. The fair value of the Company's Term Loan B Facility was approximately $822.4 million and $814.9 million as of March 31, 2021 and December 31, 2020, respectively. The fair value of the Company's Senior Notes was approximately $438.3 million and $439.9 million as of March 31, 2021 and December 31, 2020, respectively. Fair Value Measurements on a Recurring Basis The following tables set forth financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. (in millions) Fair Value March 31, 2021 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 1.3 $ — $ 1.3 Total current assets at fair value — 1.3 — 1.3 Total assets at fair value $ — $ 1.3 $ — $ 1.3 Current liabilities: Foreign currency exchange contracts $ — $ 0.4 $ — $ 0.4 Total current liabilities at fair value — 0.4 — 0.4 Total liabilities at fair value $ — $ 0.4 $ — $ 0.4 (in millions) Fair Value December 31, 2020 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 2.0 $ — $ 2.0 Total current assets at fair value — 2.0 — 2.0 Total assets at fair value $ — $ 2.0 $ — $ 2.0 Current liabilities: Foreign currency exchange contracts $ — $ 0.6 $ — $ 0.6 Total current liabilities at fair value — 0.6 — 0.6 Total liabilities at fair value $ — $ 0.6 $ — $ 0.6 Fair Value Measurements on a Nonrecurring Basis The Company's assets and liabilities that are measured at fair value on a nonrecurring basis are primarily property, plant and equipment, operating lease right-of-use assets, goodwill and other intangible assets. These fair value measurements are generally determined when there is a transaction involving those assets and liabilities, such as a purchase transaction, a business combination or an adjustment for impairment. See Note 5, "Goodwill and Other Intangible Assets — Net," for information regarding the impairment charge resulting from the fair value measurement of the Company's indefinite-lived intangible assets in the EMEA region performed on a nonrecurring basis as of March 31, 2020. The Company determined that the majority of the inputs used to value its EMEA region indefinite-lived intangible assets for the quarter ended March 31, 2020, were unobservable inputs that fall within Level 3 of the fair value hierarchy and include the following: Long Term Growth Rate 2.0% Discount Rate 12.0% Pre-Tax Royalty Rate 1.50% - 2.25%

Contingencies and Significant E

Contingencies and Significant Estimates	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies and Significant Estimates	Contingencies and Significant Estimates Product-Related and Environmental Matters As of March 31, 2021 and December 31, 2020, the Company had reserved $39.6 million and $39.9 million, respectively, for product-related warranty claims expected to be paid. Certain of these warranty and other related claims involve matters in dispute that will ultimately be resolved by negotiations, arbitration or litigation. See Note 12, "Product Warranties," for further information. As of March 31, 2021, the Company has various product liability lawsuits pending. For products sold outside of the U.S. and Canada, the Company is insured by third-party insurance companies. For products sold in the U.S. and Canada, the Company is insured, to the extent permitted under applicable law, with self-insurance retention levels. The Company's self-insurance retention levels vary by business and fluctuate with the Company's risk management practices. Product liability reserves are included in "Accrued expenses and other liabilities" in the Consolidated Balance Sheets and totaled $1.5 million and $1.7 million as of March 31, 2021 and December 31, 2020, respectively, consisting of $0.7 million and $0.9 million, respectively, reserved for specific cases and $0.8 million reserved using actuarial methods and anticipated to have occurred but are not yet reported as of both March 31, 2021 and December 31, 2020. Based on the Company's experience in defending product liability claims, management believes the reserves are adequate for estimated case resolutions on aggregate self-insured claims and third-party insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers. Such recoveries are not recorded until the associated contingencies are resolved and the recoveries are realizable. As of March 31, 2021 and December 31, 2020, the Company held reserves for environmental matters related to certain of its current and former facilities of $0.5 million and $0.8 million, respectively, which are included in "Accrued expenses and other liabilities" in the Company's Consolidated Balance Sheets. As of March 31, 2021, there have been no other claims asserted for soil or groundwater contamination at any of the Company’s other facilities, but there can be no assurance that such claims will not arise in the future. The ultimate cost of any remediation that may be required will depend upon the results of future investigation and is not reasonably estimable. Based upon available information, the Company does not expect the ultimate costs of any required remediation at any of these facilities will have a material adverse effect on its financial condition, results of operations or cash flows individually or in the aggregate. It is reasonably possible that the estimates for product warranty, product liability and environmental remediation costs may change based upon new information that may arise or matters that are beyond the scope of the Company's historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes. Other Contingencies The Company is subject to litigation, government inquiries, audits, commercial disputes, claims and other legal proceedings arising in the ordinary course of business. From time to time, the Company may be subject to audits by tax, export, customs and other governmental authorities or incur routine and non-routine fees, expenses or penalties relating to compliance with complex laws and regulations impacting the Company's business. The Company records accruals for anticipated losses related to legal and other matters, which are both probable and reasonably estimable, as well as for related legal costs as incurred. The Company believes that it has adequately accrued for such matters as of March 31, 2021 and December 31, 2020, respectively, based on the best available informa tion. In the opinion of management, the ultimate resolution of such legal and other matters is not expected to have, individually or in the aggregate, a material adverse effect on the Company's financial condition, results of operations or cash flows. As previously disclosed, the Company voluntarily disclosed to U.S. Customs and Border Protection ("CBP") certain errors in the declaration of imported products relating to quantity, value, classification, North American Free Trade Agreement eligibility and other matters as well as potential violations of antidumping and countervailing duties. Following such disclosures, the Company began a comprehensive review of its import practices in order to quantify the loss of revenue to CBP. In April 2020, the Company determined based on its continued analysis and testing of relevant records of import activity, a potential range of loss was both probable and reasonably estimable. As no amount within the range of loss was more likely than any other, the Company recorded a $3.1 million charge as of March 31, 2020, representing the low end of the range of potential loss. The Company continued its analysis and testing of import activity and rel evant records throughout 2020 and updated the range of loss to reflect the status of the analysis and testing results as of each quarter-end. As of December 31, 2020, the Company concluded its analysis and testing of import activity and determined that an amount of $3.1 million was due to the CBP. In February 2021, the Company submitted the completed analysis to CBP and remitted the aforementioned amount due. Significant judgment was required in determining the amounts due to the CBP and although the Company believes its estimate to be reasonable, no assurance can be given that the final outcome of this matter will be consistent with what has been recorded and remitted by the Company. To the extent that the final outcome of this matter is different than the amounts recorded, such differences will be recorded in the period in which such determination is made.

Product Warranties

Product Warranties	3 Months Ended
	Mar. 31, 2021
Guarantees and Product Warranties [Abstract]
Product Warranties	Product Warranties In the normal course of business, the Company provides its customers with product warranties covering workmanship, and in some cases materials, on products manufactured by the Company. Such product warranties generally provide that products will be free from defects for periods ranging from 12 to 60 months, with certain equipment having longer-term warranties. If a product fails to comply with the Company's warranty, the Company may be obligated, at its expense, to correct any defect by repairing or replacing such defective products. The Company accrues an estimate of costs that may be incurred under the product warranty at the time the product revenue is recognized. These costs include estimates of labor and materials, as necessary, associated with repair or replacement of the products. The primary factors which impact the warranty liability include the number of units shipped and historical and anticipated warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liability on an ongoing basis and adjusts the liability as determined necessary. The product warranty liability activity for the three months ended March 31, 2021 is as follows: (in millions) Balance as of December 31, 2020 (1) $ 39.9 Additions for issuance of warranties 6.5 Settlements (in cash or in kind) (6.8) Balance as of March 31, 2021 (1) $ 39.6 (1) Long-term product warranty liabilities are included in "Other long-term liabilities" and totaled $10.2 million and $10.0 million as of March 31, 2021 and December 31, 2020, respectively.

Employee Benefit Plans

Employee Benefit Plans	3 Months Ended
	Mar. 31, 2021
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans The Company sponsors and maintains defined benefit retirement plans ("Pension Plans") and postretirement health and other plans ("Postretirement Health and Other Plans") (collectively "Defined Benefit Plans") for certain retired and resigned employees. Benefits under the employee retirement plans are primarily based on years of service and compensation during the years immediately preceding retirement. The current plans are based largely upon benefit plans maintained prior to the Spin-off and are generally closed to new participants. The components of periodic benefit costs for the Company's Defined Benefit Plans are as follows: (in millions) Three Months Ended March 31, 2021 2020 Pension Plans Postretirement Pension Plans Postretirement Interest cost of projected benefit obligations $ 0.6 $ 0.1 $ 1.0 $ — Expected return on assets (0.8) — (1.0) — Amortization of prior service cost — (0.1) — (0.1) Amortization of actuarial net loss 0.7 0.2 0.6 0.2 Net periodic benefit cost $ 0.5 $ 0.2 $ 0.6 $ 0.1 The components of periodic benefit costs are included in "Other expense (income) — net" in the Consolidated Statements of Operations.

Business Transformation Program

Business Transformation Program and Restructuring	3 Months Ended
	Mar. 31, 2021
Restructuring and Related Activities [Abstract]
Business Transformation Program and Restructuring	Business Transformation Program and Restructuring Business Transformation Program During the first quarter of 2019, the Company initiated a comprehensive operational review to validate its long-term growth and margin targets and to refine its execution plans, which culminated in launching the Business Transformation Program ("Transformation Program") in May 2019. The Transformation Program is structured in multiple phases and is focused on specific areas of opportunity including strategic sourcing, manufacturing facility workflow redesign, distribution and administrative process efficiencies and optimizing the Company's global brand platforms. The Company currently expects the Transformation Program to extend through 2021, however, the business disruption resulting from the global COVID-19 pandemic and the uncertainty around the timing and extent of its impacts may extend the timing and alter the execution costs and related savings the Company expects from this program. For the three months ended March 31, 2021 and 2020, the Transformation Program costs consist primarily of fees for consulting services. The classification of the Company's Transformation Program expenses are as follows: (in millions) Three Months Ended March 31, 2021 2020 Transformation Program expense: Cost of sales $ 0.5 $ 0.8 Selling, general and administrative expenses 1.7 10.8 Total $ 2.2 $ 11.6 Restructuring The Company takes actions to improve operating efficiencies, typically in connection with recognizing cost synergies and rationalizing the cost structure of the Company, including actions associated with the Transformation Program. These actions generally include facility rationalization, headcount reductions and organizational integration activities resulting from discrete restructuring events, which are supported by approved plans for workforce reductions. The Company's restructuring activity and balance of the restructuring liability is as follows: (in millions) 2021 Plans 2020 Plans 2019 Plans 2018 and Previous Plans Workforce reductions Workforce reductions Workforce reductions Pension withdrawal obligation Total Restructuring liability as of December 31, 2020 $ — $ 2.4 $ 0.2 $ 8.6 $ 11.2 Restructuring activities 0.1 — 0.1 — 0.2 Cash payments — (0.9) (0.1) (0.3) (1.3) Restructuring liability as of March 31, 2021 $ 0.1 $ 1.5 $ 0.2 $ 8.3 $ 10.1 As of March 31, 2021 and December 31, 2020, the current portion of the restructuring liability was $3.2 million and $4.0 million, respectively, and was included in "Accrued expenses and other liabilities" in the Consolidated Balance Sheets. As of March 31, 2021 and December 31, 2020, the long-term portion of the restructuring liability was $6.9 million and $7.2 million, respectively, and was included in "Other long-term liabilities" in the Consolidated Balance Sheets. As of both March 31, 2021 and December 31, 2020, the long-term portion of the restructuring liability is for a pension withdrawal obligation incurred in connection with the reorganization and plant restructuring of one of the Company's former operating entities and is expected to be satisfied in April of 2026 when the pension withdrawal obligation is scheduled to have been satisfied. The Company's restructuring expense by segment is as follows: (in millions) Three Months Ended March 31, 2021 2020 Americas $ — $ 2.2 EMEA 0.1 0.3 APAC 0.1 0.5 Corporate — 0.7 Total restructuring activities $ 0.2 $ 3.7 The Company's restructuring expense is reported in the Consolidated Statements of Operations as follows: (in millions) Three Months Ended March 31, 2021 2020 Cost of sales $ — $ 0.1 Restructuring and other expense 0.2 3.6 Total restructuring activities $ 0.2 $ 3.7 During the first quarter of 2021, the Company initiated the consolidation of a manufacturing facility in EMEA. As a result of this facility consolidation, the Company expects to incur total costs of $0.9 million associated with severance and related costs and inventory write-downs. During the first quarter of 2021, the Company recognized total costs of $0.1 million, which are included in "Restructuring and other expense" in the Company's Consolidated Statements of Operations for the three months ended March 31, 2021 and expects to incur the remaining costs of $0.8 million during the remainder of the year ending December 31, 2021. The Company also recognized final costs in connection with restructuring actions initiated during the fourth quarter of 2019 in the APAC region. These costs include $0.1 million of severance and related costs included in "Restructuring and other expense" in the Company's Consolidated Statements of Operations for the three months ended March 31, 2021. During the first quarter of 2020, the Company initiated restructuring actions to reduce operating expenses resulting from improved efficiencies gained from the execution of the Transformation Program. During the first quarter of 2020, the Company recognized $2.8 million of severance and related costs, consisting of $2.2 million in the Americas and $0.6 million in the Corporate division, which are included in "Restructuring and other expense" in the Company's Consolidated Statements of Operations for the three months ended March 31, 2020. During the first quarter of 2020, the Company also recognized $0.8 million of severance and related costs included in "Restructuring and other expenses" and $0.1 million of accelerated depreciation included in "Cost of sales" in connection with restructuring actions initiated during the fourth quarter of 2019 in the EMEA and APAC regions. The Company may take future restructuring actions as the efficiencies from the Transformation Program are realized, as part of its continued effort to review operating costs and streamline future staffing requirements. As the Company completes payments on each of its approved plans, the remaining restructuring liability is adjusted for the actual amounts incurred. No material adjustments for prior period restructuring liabilities were incurred during either of the three months ended March 31, 2021 and 2020, respectively.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Comprehensive (loss) income includes foreign currency translation adjustments, changes in the fair value of certain financial derivative instruments that quality for hedge accounting and actuarial gains and losses arising from the Company's employee pension and postretirement benefit obligations. The components of the Company's AOCI are as follows: (in millions) March 31, December 31, 2021 2020 Accumulated other comprehensive loss: Foreign currency translation, net of income tax benefit of $1.4 million and $1.4 million, respectively $ 12.0 $ 19.1 Derivative instrument fair market value, net of income tax expense of $1.0 million and $1.1 million, respectively (0.5) — Employee pension and postretirement benefit adjustments, net of income tax benefit of $6.4 million and $6.6 million, respectively (38.2) (38.6) Total accumulated other comprehensive loss $ (26.7) $ (19.5) The summary of changes in AOCI for the three months ended March 31, 2021 and 2020 are as follows: (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2020 $ 19.1 $ — $ (38.6) $ (19.5) Other comprehensive loss before reclassifications (7.1) (0.2) (0.2) (7.5) Reclassifications — (0.4) 0.8 0.4 Tax effect of reclassifications — 0.1 (0.2) (0.1) Net current period other comprehensive (loss) income (7.1) (0.5) 0.4 (7.2) Balance as of March 31, 2021 $ 12.0 $ (0.5) $ (38.2) $ (26.7) (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2019 $ (4.3) $ (1.6) $ (35.6) $ (41.5) Other comprehensive (loss) income before reclassifications (27.5) (1.1) 1.4 (27.2) Reclassifications — 0.6 0.7 1.3 Tax effect of reclassifications (0.7) 0.1 (0.1) (0.7) Net current period other comprehensive (loss) income (28.2) (0.4) 2.0 (26.6) Balance as of March 31, 2020 $ (32.5) $ (2.0) $ (33.6) $ (68.1) (1) Income taxes are not provided for foreign currency translation relating to indefinite investments in foreign subsidiaries, although the income tax effects within cumulative translation does include the impact of the net investment hedge transaction. Reclassification adjustments are made to avoid including items in both comprehensive (loss) income and net earnings (loss). Reclassifications from AOCI, net of tax, to income were as follows: (in millions) Three Months Ended March 31, Location 2021 2020 Losses on cash flow hedges: Foreign currency exchange contracts $ 0.4 $ (0.1) Cost of sales Commodity contracts — (0.5) Cost of sales Losses on cash flow hedges, before tax 0.4 (0.6) Tax effect (0.1) 0.1 Income tax benefit Losses on cash flow hedges, net of tax $ 0.3 $ (0.5) Amortization of pension and postretirement items: Amortization of prior service cost $ 0.1 $ 0.1 Other expense (income) — net Actuarial losses (0.9) (0.8) Other expense (income) — net Amortization of pension and postretirement items, before tax (0.8) (0.7) Tax effect 0.7 0.1 Income tax expense (benefit) Amortization of pension and postretirement items, net of tax $ (0.1) $ (0.6) Total reclassifications, net of tax $ 0.2 $ (1.1)

Earnings (Loss) Per Share

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share The Company presents earnings (loss) per share on a basic and diluted basis. Basic earnings (loss) per share is computed by dividing net earnings or (loss) by the weighted average number of common shares outstanding during the reported period. Diluted earnings (loss) per share includes the dilutive effect of common stock equivalents, consisting of stock options, restricted stock units and performance share units, using the treasury stock method. Performance share units, which are considered contingently issuable, are considered dilutive when the related performance criterion has been met. As the Company reported net earnings for the three months ended March 31, 2021, basic and diluted earnings per share are calculated as outlined above. As the Company reported a net l oss for the three month period ended March 31, 2020, basic loss per share is the same as diluted loss per share as the inclusion of potential shares of common stock would be antidilutive. The components of weighted average basic and diluted shares outstanding are as follows: Three Months Ended March 31, 2021 2020 Weighted average shares outstanding — Basic 141,622,281 141,430,614 Effect of dilutive securities: Stock options 70,226 — Unvested restricted stock units 496,605 — Effect of dilutive securities 566,831 — Weighted average shares outstanding — Diluted 142,189,112 141,430,614 For the three months ended March 31, 2021 there were 0.9 million securities excluded fro m the computation of earnings per share because the effect of including such securities would have been antidilutive. In addition, certain performance share units whose conditions were not met at the end of the respective reporting periods have also been excluded from the computation of earnings per share. As a result of the Company's net loss for the three months ended March 31, 2020, all of the potentially issuable common stock was excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive, even though the exercise price could be less than the average market price of the common shares. As of March 31, 2020, the total number of shares of common stock issuable pursuant to the Company's outstanding stock-based compensation awards is as follows: March 31, 2020 Potential shares of common stock: Stock options 2,372,495 Unvested restricted stock units 575,758 Unvested performance share units (1) 691,494 Total potential shares of common stock 3,639,747

Business Segments

Business Segments	3 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Business Segments	Business Segments The Company identifies its geographic business segments using the "management approach," which designates the internal organization used by management for making operating decisions and assessing performance as the source for determining the Company's geographic business segments. Management organizes and manages the business based on three geographic business segments: the Americas, EMEA and APAC. The accounting policies of the Company's geographic business segments are the same as those described in Note 2, "Basis of Presentation and Summary of Significant Accounting Policies." The Company evaluates segment performance based on an "Adjusted Operating EBITDA" metric. Adjusted Operating EBITDA, a non-GAAP financial measure, is defined as net earnings before interest expense, income taxes, other income or expense, depreciation and amortization expense plus certain other items such as loss from impairment of assets, gain or loss from disposal of assets, restructuring activities, separation expense, loss on modification or extinguishment of debt, acquisition-related transaction and integration costs, Transformation Program expense and certain other items. In addition, certain corporate-level expenses and eliminations are not allocated to the segments. These unallocated expenses include corporate overhead, stock-based compensation expense and certain other non-operating expenses. The Company's presentation of Adjusted Operating EBITDA may not be comparable to similar measures used by other companies and are not necessarily indicative of the results of operations that would have occurred had each operating business segment been an independent, stand-alone entity during the periods presented. The following table presents financial information relating to the Company's geographic business segments, reconciled to "Net sales" and "Earnings (loss) before income taxes" included in the Company's Consolidated Statements of Operations presented in accordance with U.S. GAAP as follows: (in millions, except percentage data) Three Months Ended March 31, 2021 2020 Net sales: Americas $ 246.4 $ 250.5 EMEA 93.4 90.0 APAC 48.7 51.3 Elimination of intersegment sales (71.7) (62.9) Total net sales $ 316.8 $ 328.9 Segment Adjusted Operating EBITDA: Americas $ 50.3 $ 52.3 EMEA 14.6 13.6 APAC 6.8 8.2 Total Segment Adjusted Operating EBITDA 71.7 74.1 Corporate and unallocated expenses (21.9) (28.6) Amortization expense (10.5) (10.0) Depreciation expense (5.4) (5.2) Transaction costs (1) — (0.1) Other items (2) — (3.1) Transformation Program expense (3) (2.2) (11.6) Restructuring activities (4) (0.2) (3.7) Loss from impairment and disposal of assets — net — (11.2) Earnings from operations 31.5 0.6 Interest expense (5) (18.7) (22.4) Other (expense) income — net (5) (3.0) 6.5 Earnings (loss) before income taxes $ 9.8 $ (15.3) (1) Transaction costs are associated with acquisition and integrated-related activities. Professional services and other direct acquisition and integration costs recorded in "Selling, general and administrative expenses" were $0.1 million for the three months ended March 31, 2020. (2) Other items are costs which are not representative of the Company's operational performance. For the three months ended March 31, 2020, other items represent the changes in the loss contingency estimate of amounts due for customs duties, fees and interest on previously imported products, which are included in "Restructuring and other expenses." Refer to Note 11, "Contingencies and Significant Estimates" for discussion of the impact to the Consolidated Statements of Operations. (3) Transformation Program expense includes consulting and other costs associated with executing the Company's Transformation Program initiatives. Refer to Note 14, "Business Transformation Program and Restructuring" for discussion of the impact on the Consolidated Statements of Operations. (4) Restructuring activities include costs associated with actions to improve operating efficiencies and rationalization of the Company's cost structure. Refer to Note 14, "Business Transformation Program and Restructuring" for discussion of the impact on the Consolidated Statements of Operations. (5) As disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, amortization of debt issuance costs previously included as a component of "Other expense (income) — net" totaled $1.1 million for the three months ended March 31, 2020 and has been reclassified to include as a component of "Interest expense" in the Company's Consolidated Statements of Operations. Adjusted Operating EBITDA % by segment (6) : Americas 20.4 % 20.9 % EMEA 15.6 % 15.1 % APAC 14.0 % 16.0 % (6) Adjusted Operating EBITDA % is calculated by dividing Adjusted Operating EBITDA by net sales for each respective segment. (in millions) Three Months Ended March 31, 2021 2020 Third-party net sales by geographic area (7) : United States $ 206.4 $ 204.4 Other Americas 16.9 18.5 EMEA 58.9 69.2 APAC 34.6 36.8 Total net sales by geographic area $ 316.8 $ 328.9 (7) Third-party net sales in the section above are attributed to geographic regions based on location of customer. Net sales by product class and geographic business segment are as follows: (in millions) Three Months Ended March 31, 2021 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 182.3 $ 38.7 $ 221.0 EMEA 51.1 9.9 61.0 APAC 27.9 6.9 34.8 Total net sales $ 261.3 $ 55.5 $ 316.8 (in millions) Three Months Ended March 31, 2020 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 182.0 $ 36.1 $ 218.1 EMEA 56.0 15.6 71.6 APAC 32.0 7.2 39.2 Total net sales $ 270.0 $ 58.9 $ 328.9 Total assets by geographic segment are as follows: (in millions) March 31, December 31, 2021 2020 Americas $ 1,512.7 $ 1,488.0 EMEA 342.3 347.6 APAC 205.5 209.0 Corporate 105.0 97.0 Total assets $ 2,165.5 $ 2,141.6

Subsidiary Guarantors and Senio

Subsidiary Guarantors and Senior Notes	3 Months Ended
	Mar. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Subsidiary Guarantors and Senior Notes	Subsidiary Guarantors and Senior NotesThe following tables present consolidating financial information for (a) Welbilt ("Parent"); (b) the guarantors of the Senior Notes, which include substantially all of the domestic, 100% owned subsidiaries of Welbilt ("Guarantor Subsidiaries"); and (c) the wholly-owned foreign subsidiaries of Welbilt, which do not guarantee the Senior Notes ("Non-Guarantor Subsidiaries"). The information includes elimination entries necessary to consolidate the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries. Investments in subsidiaries are accounted for using the equity method of accounting. The principal elimination entries eliminate investments in subsidiaries, equity and intercompany balances and transactions. Separate financial statements of the Guarantor Subsidiaries are not presented because as guarantors, these subsidiaries are fully and unconditionally, jointly and severally liable under the guarantees, except for normal and customary release provisions. (Unaudited) (in millions) Three Months Ended March 31, 2021 Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 226.1 $ 195.7 $ (105.0) $ 316.8 Cost of sales — 163.5 140.5 (105.0) 199.0 Gross profit — 62.6 55.2 — 117.8 Selling, general and administrative expenses 16.3 31.2 28.5 — 76.0 Amortization expense — 7.0 3.1 — 10.1 Restructuring and other expense — — 0.2 — 0.2 (Loss) earnings from operations (16.3) 24.4 23.4 — 31.5 Interest expense 20.1 0.2 (1.6) — 18.7 Other (income) expense — net (16.2) (5.4) 13.1 11.5 3.0 Equity in earnings of subsidiaries 32.5 9.7 — (42.2) — Earnings before income taxes 12.3 39.3 11.9 (53.7) 9.8 Income tax (benefit) expense (7.1) 6.8 2.2 — 1.9 Net earnings $ 19.4 $ 32.5 $ 9.7 $ (53.7) $ 7.9 Total other comprehensive loss, net of tax (7.2) (7.5) (7.2) 14.7 (7.2) Comprehensive income $ 12.2 $ 25.0 $ 2.5 $ (39.0) $ 0.7 WELBILT, INC. Consolidating Statement of Operations (Unaudited) Three Months Ended March 31, 2020 (in millions) Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 233.1 $ 210.9 $ (115.1) $ 328.9 Cost of sales — 170.0 159.2 (115.1) 214.1 Gross profit — 63.1 51.7 — 114.8 Selling, general and administrative expenses 18.1 32.8 35.6 — 86.5 Amortization expense — 7.1 2.6 — 9.7 Restructuring and other expense 0.7 4.8 1.3 — 6.8 Loss from impairment and disposal of assets — net — — 11.2 — 11.2 (Loss) earnings from operations (18.8) 18.4 1.0 — 0.6 Interest expense 21.9 0.2 0.3 — 22.4 Other (income) expense — net (5.2) (6.3) 5.0 — (6.5) Equity in earnings (loss) of subsidiaries 5.0 (4.4) — (0.6) — (Loss) earnings before income taxes (30.5) 20.1 (4.3) (0.6) (15.3) Income tax (benefit) expense (15.4) 15.1 0.1 — (0.2) Net (loss) earnings $ (15.1) $ 5.0 $ (4.4) $ (0.6) $ (15.1) Total other comprehensive loss, net of tax (26.6) (25.0) (24.6) 49.6 (26.6) Comprehensive loss $ (41.7) $ (20.0) $ (29.0) $ 49.0 $ (41.7) WELBILT, INC. Consolidating Balance Sheet (Unaudited) (in millions) March 31, 2021 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 10.0 $ 3.6 $ 126.7 $ — $ 140.3 Restricted cash — — 0.5 — 0.5 Accounts receivable — net 0.3 83.9 90.3 — 174.5 Inventories — net — 109.7 93.5 — 203.2 Prepaids and other current assets 24.6 3.6 21.9 (0.2) 49.9 Total current assets 34.9 200.8 332.9 (0.2) 568.4 Property, plant and equipment — net 14.3 70.2 45.1 — 129.6 Operating lease right-of-use assets 2.2 3.5 40.0 — 45.7 Goodwill — 832.5 106.0 — 938.5 Other intangible assets — net 0.2 308.2 144.9 — 453.3 Intercompany long-term notes receivable — 5.8 — (5.8) — Due from affiliates — 3,490.0 — (3,490.0) — Investment in subsidiaries 4,518.4 — — (4,518.4) — Other non-current assets 8.9 3.6 17.5 — 30.0 Total assets $ 4,578.9 $ 4,914.6 $ 686.4 $ (8,014.4) $ 2,165.5 Liabilities and equity Current liabilities: Trade accounts payable $ — $ 46.8 $ 55.6 $ (0.2) $ 102.2 Accrued expenses and other liabilities 20.3 57.3 58.3 — 135.9 Current portion of long-term debt and finance leases — 0.5 0.6 — 1.1 Product warranties — 18.7 10.7 — 29.4 Total current liabilities 20.3 123.3 125.2 (0.2) 268.6 Long-term debt and finance leases 1,444.6 0.2 0.7 — 1,445.5 Deferred income taxes 43.9 (0.7) 31.7 — 74.9 Pension and postretirement health liabilities 11.9 10.2 3.2 — 25.3 Intercompany long-term notes payable 5.8 — — (5.8) — Due to affiliates 2,759.9 — 730.1 (3,490.0) — Investment in subsidiaries — 244.4 — (244.4) — Operating lease liabilities 2.0 2.1 32.4 — 36.5 Other long-term liabilities 12.9 16.7 7.5 — 37.1 Total non-current liabilities 4,281.0 272.9 805.6 (3,740.2) 1,619.3 Total equity (deficit) 277.6 4,518.4 (244.4) (4,274.0) 277.6 Total liabilities and equity $ 4,578.9 $ 4,914.6 $ 686.4 $ (8,014.4) $ 2,165.5 WELBILT, INC. Consolidating Balance Sheet (Unaudited) (in millions) December 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 8.6 $ — $ 116.6 $ (0.2) $ 125.0 Restricted cash — — 0.4 — 0.4 Accounts receivable — net 0.4 72.0 93.5 — 165.9 Inventories — net — 83.4 97.2 — 180.6 Prepaids and other current assets 24.2 2.5 23.4 — 50.1 Total current assets 33.2 157.9 331.1 (0.2) 522.0 Property, plant and equipment — net 14.2 70.6 44.3 — 129.1 Operating lease right-of-use assets 2.2 3.9 41.4 — 47.5 Goodwill — 832.4 110.5 — 942.9 Other intangible assets — net 0.2 315.6 153.8 — 469.6 Intercompany long-term notes receivable — 5.8 9.9 (15.7) — Due from affiliates — 3,509.9 — (3,509.9) — Investment in subsidiaries 4,485.8 — — (4,485.8) — Other non-current assets 8.3 4.4 17.8 — 30.5 Total assets $ 4,543.9 $ 4,900.5 $ 708.8 $ (8,011.6) $ 2,141.6 Liabilities and equity Current liabilities: Trade accounts payable $ — $ 44.0 $ 42.5 $ (0.1) $ 86.4 Accrued expenses and other liabilities 33.6 66.1 64.5 — 164.2 Current portion of long-term debt and finance leases — 0.4 0.6 — 1.0 Product warranties — 19.7 10.2 — 29.9 Total current liabilities 33.6 130.2 117.8 (0.1) 281.5 Long-term debt and finance leases 1,406.7 0.3 0.8 — 1,407.8 Deferred income taxes 43.4 — 33.1 — 76.5 Pension and postretirement health liabilities 12.9 10.2 4.7 — 27.8 Intercompany long-term notes payable 15.7 — — (15.7) — Due to affiliates 2,743.0 — 766.9 (3,509.9) — Investment in subsidiaries — 254.2 — (254.2) — Operating lease liabilities 2.1 2.3 33.3 — 37.7 Other long-term liabilities 13.4 17.5 6.4 — 37.3 Total non-current liabilities 4,237.2 284.5 845.2 (3,779.8) 1,587.1 Total equity (deficit) 273.1 4,485.8 (254.2) (4,231.7) 273.0 Total liabilities and equity $ 4,543.9 $ 4,900.5 $ 708.8 $ (8,011.6) $ 2,141.6 WELBILT, INC. Consolidating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2021 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash (used in) provided by operating activities $ (42.5) $ (14.8) $ 40.7 $ 0.2 $ (16.4) Cash flows from investing activities Capital expenditures (0.6) (1.4) (2.7) — (4.7) Intercompany investment — 19.9 (27.0) 7.1 — Net cash (used in) provided by investing activities (0.6) 18.5 (29.7) 7.1 (4.7) Cash flows from financing activities Proceeds from long-term debt 58.0 — — — 58.0 Repayments on long-term debt and finance leases (21.0) (0.1) (0.2) — (21.3) Exercises of stock options 0.5 — — — 0.5 Payments on tax withholdings for equity awards (0.1) — — — (0.1) Intercompany financing 7.1 — — (7.1) — Net cash provided by (used in) financing activities 44.5 (0.1) (0.2) (7.1) 37.1 Effect of exchange rate changes on cash — — (0.6) — (0.6) Net increase in cash and cash equivalents and restricted cash 1.4 3.6 10.2 0.2 15.4 Balance at beginning of period 8.6 — 117.0 (0.2) 125.4 Balance at end of period $ 10.0 $ 3.6 $ 127.2 $ — $ 140.8 WELBILT, INC. Consolid ating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash (used in) provided by operating activities $ (69.7) $ (4.5) $ 1.7 $ — $ (72.5) Cash flows from investing activities Capital expenditures — (4.5) (1.1) — (5.6) Intercompany investment — 7.6 (7.1) (0.5) — Other (3.9) — — — (3.9) Net cash (used in) provided by investing activities (3.9) 3.1 (8.2) (0.5) (9.5) Cash flows from financing activities Proceeds from long-term debt 128.0 — — — 128.0 Repayments on long-term debt and finance leases (23.0) (0.2) (0.1) — (23.3) Exercises of stock options 1.1 — — — 1.1 Payments on tax withholdings for equity awards (0.7) — — — (0.7) Intercompany financing (0.5) — — 0.5 — Net cash provided by (used in) financing activities 104.9 (0.2) (0.1) 0.5 105.1 Effect of exchange rate changes on cash — — (5.3) — (5.3) Net increase (decrease) in cash and cash equivalents and restricted cash 31.3 (1.6) (11.9) — 17.8 Balance at beginning of period 10.7 0.7 119.3 — 130.7 Balance at end of period $ 42.0 $ (0.9) $ 107.4 $ — $ 148.5

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event On April 20, 2021, the Company entered into an Agreement and Plan of Merger ("Merger Agreement") with The Middleby Corporation ("Middleby"), Middleby Marshall Inc., a wholly owned subsidiary of Middleby ("Acquiror") and Mosaic Merger Sub, Inc., a wholly owned subsidiary of the Acquiror ("Merger Sub"). At the time of the merger, Merger Sub will merge with and into Welbilt, Inc., with the Company surviving as an indirect wholly owned subsidiary of Middleby (the "Merger"). Subject to the terms and conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of the Company's common stock, $0.01 per share, issued and outstanding immediately prior to the effective time of the Merger will be converted into the right to receive 0.1240 shares of validly issued, fully paid and non-assessable shares of common stock, par value $0.01 per share, of Middleby common stock. Upon closing of the Merger, Middleby stockholders will own approximately 76% and the Company's stockholders will own approximately 24% of the combined company. The respective boards of directors of the Company and Middleby have unanimously approved the Merger Agreement. The board of directors of the Company have agreed to recommend that the Company’s stockholders adopt the Merger Agreement, and the board of directors of Middleby have agreed to recommend that Middleby’s stockholders approve the issuance of the shares of Middleby Common Stock in connection with the Merger. The completion of the Merger is subject to the satisfaction or waiver of customary closing conditions, including: (i) expiration or termination of any waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (ii) receipt of applicable approvals under certain foreign competition, antitrust or merger control laws, (iii) there being no law or order prohibiting consummation of the Merger, (iv) subject to specified materiality standards, the accuracy of the representations and warranties of the parties, (v) compliance by the parties in all material respects with their respective covenants, and (vi) the absence of a material adverse effect with respect to each of the Company and Middleby. The completion of the Merger is not conditioned upon receipt of financing by Middleby and the Merger is expected to close in late 2021.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of Welbilt and its wholly-owned subsidiaries and have been prepared by the Company, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). The Company prepares its financial statements in accordance with accounting principles generally accepted in the U.S. ("U.S. GAAP"). All intercompany balances and transactions between the Company and its affiliates have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include inventory obsolescence costs, warranty costs, product liability costs, employee benefit programs, sales rebates and the measurement of income tax assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates. The ongoing COVID-19 pandemic has created and may continue to create significant uncertainty in the macroeconomic environment which, in addition to other unforeseen effects of this pandemic, may adversely impact the Company's future operating results. As a result, many of the Company's estimates and assumptions may require increased judgment and involve a higher degree of variability and volatility. As the impacts of the pandemic continue to evolve and additional information becomes available, these estimates may change materially in future periods.
Government Assistance	Government Assistance The Company's policy for government assistance is to recognize the assistance when there is reasonable assurance that the Company has met the substantive conditions of and requirements for receiving the assistance. The government assistance is recorded as a reduction to the related expense to which the assistance relates. Beginning in the second quarter of 2020, as a result of the COVID-19 pandemic, governments in various jurisdictions in which the Company operates have provided financial assistance designed to offset salary expenditures associated with companies maintaining their pre-pandemic employee headcount levels. The Company has applied and will continue to apply for such assistance programs where relevant requirements and conditions have been met.
Recently Adopted and Not Yet Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04") to provide temporary optional expedients and exceptions to U.S. GAAP guidance on contract modifications, hedge accounting and other transactions affected by the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. ASU 2020-04 is effective upon issuance and the Company may elect to apply the standard through December 31, 2022. This guidance primarily impacts the interest expense under the Company's 2016 Credit Facility which utilizes LIBOR as a basis. As the Company has not executed a modification of the interest component of this financial instrument and does not have related outstanding hedges in place as of March 31, 2021, the guidance has not impacted the Company's consolidated financial statements to date. The Company will evaluate the impact of adopting this guidance at the time such transition to an alternative reference rate occurs. In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" ("ASU 2019-12"), which amends, and is intended to simplify, existing guidance related to the accounting for income taxes. ASU 2019-12 was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted ASU 2019-12 prospectively as of January 1, 2021 which did not have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact on the Company.

Accounting Policies (Tables)

Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Schedule of Government Assistance Received	Government assistance has been reflected as a reduction to the related expense for which the assistance relates as follows: (in millions) Three Months Ended March 31, 2021 Reduction to related expense (1) : Cost of sales $ 0.4 Selling, general and administrative expenses 0.8 Total $ 1.2 As of March 31, 2021 and December 31, 2020, $0.6 million and $1.9 million, respectively, of government assistance was included as a reduction in capitalized labor, and is included as a component of "Inventories — net". This portion of government assistance will be recognized as a reduction to "Cost of sales" when the associated inventory is sold.

Inventories - Net (Tables)

Inventories - Net (Tables)	3 Months Ended
	Mar. 31, 2021
Inventory Disclosure [Abstract]
Components of Inventories	The components of "Inventories — net" are as follows: (in millions) March 31, December 31, 2021 2020 Inventories — net: Raw materials $ 92.5 $ 85.6 Work-in-process 14.9 13.9 Finished goods 100.1 85.4 Total inventories at FIFO cost 207.5 184.9 LIFO Reserve (4.3) (4.3) Total inventories — net $ 203.2 $ 180.6

Property, Plant and Equipment_2

Property, Plant and Equipment - Net (Tables)	3 Months Ended
	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	The components of "Property, plant and equipment — net" are as follows: (in millions) March 31, December 31, 2021 2020 Property, plant and equipment — net: Land $ 9.7 $ 9.7 Building and improvements 100.6 99.8 Machinery, equipment and tooling 231.2 231.7 Furniture and fixtures 8.1 8.1 Computer hardware and software for internal use 67.6 66.8 Construction in progress 13.2 14.1 Total cost 430.4 430.2 Less accumulated depreciation (300.8) (301.1) Total property, plant and equipment — net $ 129.6 $ 129.1

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets - Net (Tables)	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the Carrying Amount of Goodwill by Geographic Segment	The changes in the carrying amount of goodwill by geographic business segment are as follows: (in millions) Americas EMEA APAC Total Goodwill balance at December 31, 2020 (1) $ 832.6 $ 89.3 $ 21.0 $ 942.9 Foreign currency impact — (4.3) (0.1) (4.4) Goodwill balance at March 31, 2021 $ 832.6 $ 85.0 $ 20.9 $ 938.5
Changes in Gross Carrying Amount and Balances of Finite-Lived Intangible Assets	The gross carrying amounts, impairment charges and accumulated amortization of the Company's intangible assets, other than goodwill, are as follows: (in millions) March 31, 2021 December 31, 2020 Gross Accumulated Net Gross Impairment Charges Accumulated Net Customer relationships $ 476.4 $ (277.5) $ 198.9 $ 479.1 $ — $ (271.6) $ 207.5 Trademarks and trade names 209.2 (0.2) 209.0 223.1 (11.1) — 212.0 Other intangibles 170.7 (128.8) 41.9 173.1 — (126.6) 46.5 Patents 5.8 (2.3) 3.5 5.8 — (2.2) 3.6 Total $ 862.1 $ (408.8) $ 453.3 $ 881.1 $ (11.1) $ (400.4) $ 469.6
Changes in Gross Carrying Amount and Balances of Indefinite-Lived Intangible Assets	The gross carrying amounts, impairment charges and accumulated amortization of the Company's intangible assets, other than goodwill, are as follows: (in millions) March 31, 2021 December 31, 2020 Gross Accumulated Net Gross Impairment Charges Accumulated Net Customer relationships $ 476.4 $ (277.5) $ 198.9 $ 479.1 $ — $ (271.6) $ 207.5 Trademarks and trade names 209.2 (0.2) 209.0 223.1 (11.1) — 212.0 Other intangibles 170.7 (128.8) 41.9 173.1 — (126.6) 46.5 Patents 5.8 (2.3) 3.5 5.8 — (2.2) 3.6 Total $ 862.1 $ (408.8) $ 453.3 $ 881.1 $ (11.1) $ (400.4) $ 469.6

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	3 Months Ended
	Mar. 31, 2021
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Liabilities	The components of "Accrued expenses and other liabilities" are as follows: (in millions) March 31, December 31, 2021 2020 Accrued expenses and other liabilities: Miscellaneous accrued expenses $ 38.5 $ 37.5 Employee related expenses 32.6 35.6 Accrued rebates and commissions 28.3 40.1 Current portion of operating lease liabilities 9.3 9.7 Interest payable 6.0 16.1 Customer deposits 5.0 3.9 Non-income taxes payable 3.6 3.6 Restructuring liabilities 3.2 4.0 Deferred revenues 2.9 2.9 Pension and postretirement health liabilities 2.1 2.1 Business Transformation Program related expenses 1.5 0.8 Product liabilities 1.5 1.7 Income and other taxes payable 1.0 5.6 Derivative liabilities 0.4 0.6 Total accrued expenses and other liabilities $ 135.9 $ 164.2

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	The carrying value of the Company's outstanding debt consists of the following: (in millions, except percentage data) March 31, 2021 December 31, 2020 Carrying Value Weighted Average Interest Rate Carrying Value Weighted Average Interest Rate Long-term debt and finance leases: Revolving Credit Facility $ 180.0 4.44 % $ 143.0 4.21 % Term Loan B Facility 855.0 2.96 % 855.0 3.45 % 9.50% Senior Notes due 2024 425.0 9.72 % 425.0 9.72 % Finance leases 2.0 4.63 % 2.2 4.80 % Total debt and finance leases, including current portion 1,462.0 1,425.2 Less current portion: Finance leases (1.1) (1.0) Unamortized debt issuance costs (1) (15.7) (16.7) Hedge accounting fair value adjustment (2) 0.3 0.3 Total long-term debt and finance leases $ 1,445.5 $ 1,407.8 Total debt issuance costs, net of amortization as of March 31, 2021 and December 31, 2020, were $19.0 million and $20.3 million, respectively, of which $3.3 million and $3.6 million, respectively, are related to the Revolving Credit Facility and recorded in "Other non-current assets" in the Consolidated Balance Sheets. As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, amortization of debt issuance costs previously included as a component of "Other expense (income) — net" totaled $1.1 million for the three months ended March 31, 2020 and has been reclassified to include as a component of "Interest expense" in the Company's Consolidated Statements of Operations. (2) Balance represents deferred gains from the terminations of interest rate swaps designated as fair value hedges.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Outstanding Commodity and Currency Forward Contracts	The outstanding currency forward contracts which were entered into as hedges of forecasted transactions and continue to qualify for hedge accounting are as follows: Currency (in millions) Units Hedged March 31, December 31, 2021 2020 Canadian Dollar 9.2 6.4 Euro 5.1 3.3 British Pound 3.2 6.1 Mexican Peso 92.4 92.8 Singapore Dollar 2.3 2.3 The Company also had the following outstanding currency forward contracts that were not designated as hedging instruments: Currency (in millions) Contracted Units March 31, December 31, 2021 2020 Canadian Dollar 1.8 1.1 Euro 82.7 84.2 Swiss Franc 7.0 7.0 British Pound 22.5 1.0 Singapore Dollar 0.6 0.3 Mexican Peso 20.9 13.8
Schedule of Impact of Derivative Instruments on the Consolidated Statements of Comprehensive Income (Loss) and the Consolidated Statements of Operations	The effects of the Company's derivative instruments on the Consolidated Statements of Comprehensive Income (Loss) and Consolidated Statements of Operations for gains or losses initially recognized in AOCI in the Consolidated Balance Sheets were as follows: Derivatives in cash flow hedging relationships Pretax gain/(loss) recognized in AOCI Pretax gain/(loss) reclassified from AOCI into income (in millions) Three Months Ended March 31, Location Three Months Ended March 31, 2021 2020 2021 2020 Foreign currency exchange contracts $ (0.2) $ (1.1) Cost of sales $ 0.4 $ (0.1) Commodity contracts — — Cost of sales — (0.5) Total $ (0.2) $ (1.1) $ 0.4 $ (0.6) The table below presents the effect of the Company’s derivative financial instruments on the Consolidated Statements of Operations: (in millions) Location and amount of gain/(loss) recognized on effect of fair value and cash flow derivative instruments Three Months Ended Three Months Ended March 31, 2021 March 31, 2020 Cost of Sales Interest Expense Cost of Sales Interest Expense Total amounts of expense line items presented in the Consolidated Statements of Operations in which effects of fair value and cash flow hedges are recorded $ 199.0 $ 18.7 $ 214.1 $ 22.4 The effects of fair value and cash flow hedging: Gain/(loss) on fair value hedging relationship: Interest rate contract: Hedged item $ — $ — $ — $ 0.1 Gain/(loss) on cash flow hedging relationships: Foreign currency exchange contracts: Amount of gain/(loss) reclassified from AOCI into income $ 0.4 $ — $ (0.1) $ — Commodity contracts: Amount of gain/(loss) reclassified from AOCI into income $ — $ — $ (0.5) $ — The location and effects of the net investment hedge on the Consolidated Statements of Comprehensive Income (Loss) and Consolidated Statements of Operations are as follows: Derivative in net investment hedging relationship Pretax gain/(loss) recognized in AOCI Gain/(loss) reclassified from AOCI into income Gain/(loss) recognized in income (amount excluded from effectiveness testing) (in millions) Three Months Ended Location Three Months Ended Location Three Months Ended March 31, March 31, March 31, 2021 2020 2021 2020 2021 2020 Interest rate swap contract $ — $ (0.8) N/A $ — $ — Other expense (income) — net $ — $ 0.3 N/A = Not applicable
Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Assets in the Accompanying Consolidated Balance Sheet	The fair value of outstanding derivative contracts recorded as assets in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Asset Derivatives March 31, December 31, 2021 2020 Derivatives designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ 0.6 $ 1.1 Total derivatives designated as hedging instruments $ 0.6 $ 1.1 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Prepaids and other current assets $ 0.7 $ 0.9 Total derivatives NOT designated as hedging instruments $ 0.7 $ 0.9 Total asset derivatives $ 1.3 $ 2.0
Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Liabilities in the Accompanying Consolidated Balance Sheet	The fair value of outstanding derivative contracts recorded as liabilities in the Consolidated Balance Sheets are as follows: (in millions) Balance Sheet Location Liability Derivatives March 31, December 31, 2021 2020 Derivatives designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.2 $ 0.2 Total derivatives designated as hedging instruments $ 0.2 $ 0.2 Derivatives NOT designated as hedging instruments: Foreign currency exchange contracts Accrued expenses and other liabilities $ 0.2 $ 0.4 Total derivatives NOT designated as hedging instruments $ 0.2 $ 0.4 Total liability derivatives $ 0.4 $ 0.6

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis by level within the Fair Value Hierarchy	The following tables set forth financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. (in millions) Fair Value March 31, 2021 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 1.3 $ — $ 1.3 Total current assets at fair value — 1.3 — 1.3 Total assets at fair value $ — $ 1.3 $ — $ 1.3 Current liabilities: Foreign currency exchange contracts $ — $ 0.4 $ — $ 0.4 Total current liabilities at fair value — 0.4 — 0.4 Total liabilities at fair value $ — $ 0.4 $ — $ 0.4 (in millions) Fair Value December 31, 2020 Level 1 Level 2 Level 3 Total Current assets: Foreign currency exchange contracts $ — $ 2.0 $ — $ 2.0 Total current assets at fair value — 2.0 — 2.0 Total assets at fair value $ — $ 2.0 $ — $ 2.0 Current liabilities: Foreign currency exchange contracts $ — $ 0.6 $ — $ 0.6 Total current liabilities at fair value — 0.6 — 0.6 Total liabilities at fair value $ — $ 0.6 $ — $ 0.6
Fair Value Measurement Inputs and Valuation Techniques	The Company determined that the majority of the inputs used to value its EMEA region indefinite-lived intangible assets for the quarter ended March 31, 2020, were unobservable inputs that fall within Level 3 of the fair value hierarchy and include the following: Long Term Growth Rate 2.0% Discount Rate 12.0% Pre-Tax Royalty Rate 1.50% - 2.25%

Product Warranties (Tables)

Product Warranties (Tables)	3 Months Ended
	Mar. 31, 2021
Guarantees and Product Warranties [Abstract]
Schedule of the Summary of Product Warranty Activity	The product warranty liability activity for the three months ended March 31, 2021 is as follows: (in millions) Balance as of December 31, 2020 (1) $ 39.9 Additions for issuance of warranties 6.5 Settlements (in cash or in kind) (6.8) Balance as of March 31, 2021 (1) $ 39.6

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2021
Retirement Benefits [Abstract]
Schedule of Components of Period Benefit Costs	The components of periodic benefit costs for the Company's Defined Benefit Plans are as follows: (in millions) Three Months Ended March 31, 2021 2020 Pension Plans Postretirement Pension Plans Postretirement Interest cost of projected benefit obligations $ 0.6 $ 0.1 $ 1.0 $ — Expected return on assets (0.8) — (1.0) — Amortization of prior service cost — (0.1) — (0.1) Amortization of actuarial net loss 0.7 0.2 0.6 0.2 Net periodic benefit cost $ 0.5 $ 0.2 $ 0.6 $ 0.1

Business Transformation Progr_2

Business Transformation Program and Restructuring (Tables)	3 Months Ended
	Mar. 31, 2021
Restructuring and Related Activities [Abstract]
Components of Transformation Program expense	The classification of the Company's Transformation Program expenses are as follows: (in millions) Three Months Ended March 31, 2021 2020 Transformation Program expense: Cost of sales $ 0.5 $ 0.8 Selling, general and administrative expenses 1.7 10.8 Total $ 2.2 $ 11.6
Rollforward of all Restructuring Activities	The Company's restructuring activity and balance of the restructuring liability is as follows: (in millions) 2021 Plans 2020 Plans 2019 Plans 2018 and Previous Plans Workforce reductions Workforce reductions Workforce reductions Pension withdrawal obligation Total Restructuring liability as of December 31, 2020 $ — $ 2.4 $ 0.2 $ 8.6 $ 11.2 Restructuring activities 0.1 — 0.1 — 0.2 Cash payments — (0.9) (0.1) (0.3) (1.3) Restructuring liability as of March 31, 2021 $ 0.1 $ 1.5 $ 0.2 $ 8.3 $ 10.1
Restructuring Expense by Segment	The Company's restructuring expense by segment is as follows: (in millions) Three Months Ended March 31, 2021 2020 Americas $ — $ 2.2 EMEA 0.1 0.3 APAC 0.1 0.5 Corporate — 0.7 Total restructuring activities $ 0.2 $ 3.7 The Company's restructuring expense is reported in the Consolidated Statements of Operations as follows: (in millions) Three Months Ended March 31, 2021 2020 Cost of sales $ — $ 0.1 Restructuring and other expense 0.2 3.6 Total restructuring activities $ 0.2 $ 3.7

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Reconciliations for the Changes in Accumulated Other Comprehensive Loss	The components of the Company's AOCI are as follows: (in millions) March 31, December 31, 2021 2020 Accumulated other comprehensive loss: Foreign currency translation, net of income tax benefit of $1.4 million and $1.4 million, respectively $ 12.0 $ 19.1 Derivative instrument fair market value, net of income tax expense of $1.0 million and $1.1 million, respectively (0.5) — Employee pension and postretirement benefit adjustments, net of income tax benefit of $6.4 million and $6.6 million, respectively (38.2) (38.6) Total accumulated other comprehensive loss $ (26.7) $ (19.5) The summary of changes in AOCI for the three months ended March 31, 2021 and 2020 are as follows: (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2020 $ 19.1 $ — $ (38.6) $ (19.5) Other comprehensive loss before reclassifications (7.1) (0.2) (0.2) (7.5) Reclassifications — (0.4) 0.8 0.4 Tax effect of reclassifications — 0.1 (0.2) (0.1) Net current period other comprehensive (loss) income (7.1) (0.5) 0.4 (7.2) Balance as of March 31, 2021 $ 12.0 $ (0.5) $ (38.2) $ (26.7) (in millions) Foreign Currency Translation (1) Gains and Losses on Cash Flow Hedges Pension & Postretirement Total Balance as of December 31, 2019 $ (4.3) $ (1.6) $ (35.6) $ (41.5) Other comprehensive (loss) income before reclassifications (27.5) (1.1) 1.4 (27.2) Reclassifications — 0.6 0.7 1.3 Tax effect of reclassifications (0.7) 0.1 (0.1) (0.7) Net current period other comprehensive (loss) income (28.2) (0.4) 2.0 (26.6) Balance as of March 31, 2020 $ (32.5) $ (2.0) $ (33.6) $ (68.1)
Reclassification out of Accumulated Other Comprehensive Loss	Reclassifications from AOCI, net of tax, to income were as follows: (in millions) Three Months Ended March 31, Location 2021 2020 Losses on cash flow hedges: Foreign currency exchange contracts $ 0.4 $ (0.1) Cost of sales Commodity contracts — (0.5) Cost of sales Losses on cash flow hedges, before tax 0.4 (0.6) Tax effect (0.1) 0.1 Income tax benefit Losses on cash flow hedges, net of tax $ 0.3 $ (0.5) Amortization of pension and postretirement items: Amortization of prior service cost $ 0.1 $ 0.1 Other expense (income) — net Actuarial losses (0.9) (0.8) Other expense (income) — net Amortization of pension and postretirement items, before tax (0.8) (0.7) Tax effect 0.7 0.1 Income tax expense (benefit) Amortization of pension and postretirement items, net of tax $ (0.1) $ (0.6) Total reclassifications, net of tax $ 0.2 $ (1.1)

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Components of Weighted Average Basic and Diluted Shares Outstanding	The components of weighted average basic and diluted shares outstanding are as follows: Three Months Ended March 31, 2021 2020 Weighted average shares outstanding — Basic 141,622,281 141,430,614 Effect of dilutive securities: Stock options 70,226 — Unvested restricted stock units 496,605 — Effect of dilutive securities 566,831 — Weighted average shares outstanding — Diluted 142,189,112 141,430,614
Schedule of Antidilutive Potential Shares Of Common Stock	As a result of the Company's net loss for the three months ended March 31, 2020, all of the potentially issuable common stock was excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive, even though the exercise price could be less than the average market price of the common shares. As of March 31, 2020, the total number of shares of common stock issuable pursuant to the Company's outstanding stock-based compensation awards is as follows: March 31, 2020 Potential shares of common stock: Stock options 2,372,495 Unvested restricted stock units 575,758 Unvested performance share units (1) 691,494 Total potential shares of common stock 3,639,747

Business Segments (Tables)

Business Segments (Tables)	3 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Schedule of Financial Information Relating to the Company's Reportable Segments	The following table presents financial information relating to the Company's geographic business segments, reconciled to "Net sales" and "Earnings (loss) before income taxes" included in the Company's Consolidated Statements of Operations presented in accordance with U.S. GAAP as follows: (in millions, except percentage data) Three Months Ended March 31, 2021 2020 Net sales: Americas $ 246.4 $ 250.5 EMEA 93.4 90.0 APAC 48.7 51.3 Elimination of intersegment sales (71.7) (62.9) Total net sales $ 316.8 $ 328.9 Segment Adjusted Operating EBITDA: Americas $ 50.3 $ 52.3 EMEA 14.6 13.6 APAC 6.8 8.2 Total Segment Adjusted Operating EBITDA 71.7 74.1 Corporate and unallocated expenses (21.9) (28.6) Amortization expense (10.5) (10.0) Depreciation expense (5.4) (5.2) Transaction costs (1) — (0.1) Other items (2) — (3.1) Transformation Program expense (3) (2.2) (11.6) Restructuring activities (4) (0.2) (3.7) Loss from impairment and disposal of assets — net — (11.2) Earnings from operations 31.5 0.6 Interest expense (5) (18.7) (22.4) Other (expense) income — net (5) (3.0) 6.5 Earnings (loss) before income taxes $ 9.8 $ (15.3) (1) Transaction costs are associated with acquisition and integrated-related activities. Professional services and other direct acquisition and integration costs recorded in "Selling, general and administrative expenses" were $0.1 million for the three months ended March 31, 2020. (2) Other items are costs which are not representative of the Company's operational performance. For the three months ended March 31, 2020, other items represent the changes in the loss contingency estimate of amounts due for customs duties, fees and interest on previously imported products, which are included in "Restructuring and other expenses." Refer to Note 11, "Contingencies and Significant Estimates" for discussion of the impact to the Consolidated Statements of Operations. (3) Transformation Program expense includes consulting and other costs associated with executing the Company's Transformation Program initiatives. Refer to Note 14, "Business Transformation Program and Restructuring" for discussion of the impact on the Consolidated Statements of Operations. (4) Restructuring activities include costs associated with actions to improve operating efficiencies and rationalization of the Company's cost structure. Refer to Note 14, "Business Transformation Program and Restructuring" for discussion of the impact on the Consolidated Statements of Operations. (5) As disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, amortization of debt issuance costs previously included as a component of "Other expense (income) — net" totaled $1.1 million for the three months ended March 31, 2020 and has been reclassified to include as a component of "Interest expense" in the Company's Consolidated Statements of Operations. Adjusted Operating EBITDA % by segment (6) : Americas 20.4 % 20.9 % EMEA 15.6 % 15.1 % APAC 14.0 % 16.0 % (6) Adjusted Operating EBITDA % is calculated by dividing Adjusted Operating EBITDA by net sales for each respective segment. (in millions) Three Months Ended March 31, 2021 2020 Third-party net sales by geographic area (7) : United States $ 206.4 $ 204.4 Other Americas 16.9 18.5 EMEA 58.9 69.2 APAC 34.6 36.8 Total net sales by geographic area $ 316.8 $ 328.9 (7) Third-party net sales in the section above are attributed to geographic regions based on location of customer. Net sales by product class and geographic business segment are as follows: (in millions) Three Months Ended March 31, 2021 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 182.3 $ 38.7 $ 221.0 EMEA 51.1 9.9 61.0 APAC 27.9 6.9 34.8 Total net sales $ 261.3 $ 55.5 $ 316.8 (in millions) Three Months Ended March 31, 2020 Commercial Foodservice Equipment Aftermarket Parts and Support Total Americas $ 182.0 $ 36.1 $ 218.1 EMEA 56.0 15.6 71.6 APAC 32.0 7.2 39.2 Total net sales $ 270.0 $ 58.9 $ 328.9 Total assets by geographic segment are as follows: (in millions) March 31, December 31, 2021 2020 Americas $ 1,512.7 $ 1,488.0 EMEA 342.3 347.6 APAC 205.5 209.0 Corporate 105.0 97.0 Total assets $ 2,165.5 $ 2,141.6

Subsidiary Guarantors and Sen_2

Subsidiary Guarantors and Senior Notes (Tables)	3 Months Ended
	Mar. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Consolidating Statement of Operations	WELBILT, INC. Consolidating Statement of Operations (Unaudited) (in millions) Three Months Ended March 31, 2021 Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 226.1 $ 195.7 $ (105.0) $ 316.8 Cost of sales — 163.5 140.5 (105.0) 199.0 Gross profit — 62.6 55.2 — 117.8 Selling, general and administrative expenses 16.3 31.2 28.5 — 76.0 Amortization expense — 7.0 3.1 — 10.1 Restructuring and other expense — — 0.2 — 0.2 (Loss) earnings from operations (16.3) 24.4 23.4 — 31.5 Interest expense 20.1 0.2 (1.6) — 18.7 Other (income) expense — net (16.2) (5.4) 13.1 11.5 3.0 Equity in earnings of subsidiaries 32.5 9.7 — (42.2) — Earnings before income taxes 12.3 39.3 11.9 (53.7) 9.8 Income tax (benefit) expense (7.1) 6.8 2.2 — 1.9 Net earnings $ 19.4 $ 32.5 $ 9.7 $ (53.7) $ 7.9 Total other comprehensive loss, net of tax (7.2) (7.5) (7.2) 14.7 (7.2) Comprehensive income $ 12.2 $ 25.0 $ 2.5 $ (39.0) $ 0.7 WELBILT, INC. Consolidating Statement of Operations (Unaudited) Three Months Ended March 31, 2020 (in millions) Parent Guarantor Non- Consolidating Adjustments Consolidated Net sales $ — $ 233.1 $ 210.9 $ (115.1) $ 328.9 Cost of sales — 170.0 159.2 (115.1) 214.1 Gross profit — 63.1 51.7 — 114.8 Selling, general and administrative expenses 18.1 32.8 35.6 — 86.5 Amortization expense — 7.1 2.6 — 9.7 Restructuring and other expense 0.7 4.8 1.3 — 6.8 Loss from impairment and disposal of assets — net — — 11.2 — 11.2 (Loss) earnings from operations (18.8) 18.4 1.0 — 0.6 Interest expense 21.9 0.2 0.3 — 22.4 Other (income) expense — net (5.2) (6.3) 5.0 — (6.5) Equity in earnings (loss) of subsidiaries 5.0 (4.4) — (0.6) — (Loss) earnings before income taxes (30.5) 20.1 (4.3) (0.6) (15.3) Income tax (benefit) expense (15.4) 15.1 0.1 — (0.2) Net (loss) earnings $ (15.1) $ 5.0 $ (4.4) $ (0.6) $ (15.1) Total other comprehensive loss, net of tax (26.6) (25.0) (24.6) 49.6 (26.6) Comprehensive loss $ (41.7) $ (20.0) $ (29.0) $ 49.0 $ (41.7)
Consolidating Balance Sheet	WELBILT, INC. Consolidating Balance Sheet (Unaudited) (in millions) March 31, 2021 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 10.0 $ 3.6 $ 126.7 $ — $ 140.3 Restricted cash — — 0.5 — 0.5 Accounts receivable — net 0.3 83.9 90.3 — 174.5 Inventories — net — 109.7 93.5 — 203.2 Prepaids and other current assets 24.6 3.6 21.9 (0.2) 49.9 Total current assets 34.9 200.8 332.9 (0.2) 568.4 Property, plant and equipment — net 14.3 70.2 45.1 — 129.6 Operating lease right-of-use assets 2.2 3.5 40.0 — 45.7 Goodwill — 832.5 106.0 — 938.5 Other intangible assets — net 0.2 308.2 144.9 — 453.3 Intercompany long-term notes receivable — 5.8 — (5.8) — Due from affiliates — 3,490.0 — (3,490.0) — Investment in subsidiaries 4,518.4 — — (4,518.4) — Other non-current assets 8.9 3.6 17.5 — 30.0 Total assets $ 4,578.9 $ 4,914.6 $ 686.4 $ (8,014.4) $ 2,165.5 Liabilities and equity Current liabilities: Trade accounts payable $ — $ 46.8 $ 55.6 $ (0.2) $ 102.2 Accrued expenses and other liabilities 20.3 57.3 58.3 — 135.9 Current portion of long-term debt and finance leases — 0.5 0.6 — 1.1 Product warranties — 18.7 10.7 — 29.4 Total current liabilities 20.3 123.3 125.2 (0.2) 268.6 Long-term debt and finance leases 1,444.6 0.2 0.7 — 1,445.5 Deferred income taxes 43.9 (0.7) 31.7 — 74.9 Pension and postretirement health liabilities 11.9 10.2 3.2 — 25.3 Intercompany long-term notes payable 5.8 — — (5.8) — Due to affiliates 2,759.9 — 730.1 (3,490.0) — Investment in subsidiaries — 244.4 — (244.4) — Operating lease liabilities 2.0 2.1 32.4 — 36.5 Other long-term liabilities 12.9 16.7 7.5 — 37.1 Total non-current liabilities 4,281.0 272.9 805.6 (3,740.2) 1,619.3 Total equity (deficit) 277.6 4,518.4 (244.4) (4,274.0) 277.6 Total liabilities and equity $ 4,578.9 $ 4,914.6 $ 686.4 $ (8,014.4) $ 2,165.5 WELBILT, INC. Consolidating Balance Sheet (Unaudited) (in millions) December 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Assets Current assets: Cash and cash equivalents $ 8.6 $ — $ 116.6 $ (0.2) $ 125.0 Restricted cash — — 0.4 — 0.4 Accounts receivable — net 0.4 72.0 93.5 — 165.9 Inventories — net — 83.4 97.2 — 180.6 Prepaids and other current assets 24.2 2.5 23.4 — 50.1 Total current assets 33.2 157.9 331.1 (0.2) 522.0 Property, plant and equipment — net 14.2 70.6 44.3 — 129.1 Operating lease right-of-use assets 2.2 3.9 41.4 — 47.5 Goodwill — 832.4 110.5 — 942.9 Other intangible assets — net 0.2 315.6 153.8 — 469.6 Intercompany long-term notes receivable — 5.8 9.9 (15.7) — Due from affiliates — 3,509.9 — (3,509.9) — Investment in subsidiaries 4,485.8 — — (4,485.8) — Other non-current assets 8.3 4.4 17.8 — 30.5 Total assets $ 4,543.9 $ 4,900.5 $ 708.8 $ (8,011.6) $ 2,141.6 Liabilities and equity Current liabilities: Trade accounts payable $ — $ 44.0 $ 42.5 $ (0.1) $ 86.4 Accrued expenses and other liabilities 33.6 66.1 64.5 — 164.2 Current portion of long-term debt and finance leases — 0.4 0.6 — 1.0 Product warranties — 19.7 10.2 — 29.9 Total current liabilities 33.6 130.2 117.8 (0.1) 281.5 Long-term debt and finance leases 1,406.7 0.3 0.8 — 1,407.8 Deferred income taxes 43.4 — 33.1 — 76.5 Pension and postretirement health liabilities 12.9 10.2 4.7 — 27.8 Intercompany long-term notes payable 15.7 — — (15.7) — Due to affiliates 2,743.0 — 766.9 (3,509.9) — Investment in subsidiaries — 254.2 — (254.2) — Operating lease liabilities 2.1 2.3 33.3 — 37.7 Other long-term liabilities 13.4 17.5 6.4 — 37.3 Total non-current liabilities 4,237.2 284.5 845.2 (3,779.8) 1,587.1 Total equity (deficit) 273.1 4,485.8 (254.2) (4,231.7) 273.0 Total liabilities and equity $ 4,543.9 $ 4,900.5 $ 708.8 $ (8,011.6) $ 2,141.6
Consolidating Statement of Cash Flows	WELBILT, INC. Consolidating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2021 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash (used in) provided by operating activities $ (42.5) $ (14.8) $ 40.7 $ 0.2 $ (16.4) Cash flows from investing activities Capital expenditures (0.6) (1.4) (2.7) — (4.7) Intercompany investment — 19.9 (27.0) 7.1 — Net cash (used in) provided by investing activities (0.6) 18.5 (29.7) 7.1 (4.7) Cash flows from financing activities Proceeds from long-term debt 58.0 — — — 58.0 Repayments on long-term debt and finance leases (21.0) (0.1) (0.2) — (21.3) Exercises of stock options 0.5 — — — 0.5 Payments on tax withholdings for equity awards (0.1) — — — (0.1) Intercompany financing 7.1 — — (7.1) — Net cash provided by (used in) financing activities 44.5 (0.1) (0.2) (7.1) 37.1 Effect of exchange rate changes on cash — — (0.6) — (0.6) Net increase in cash and cash equivalents and restricted cash 1.4 3.6 10.2 0.2 15.4 Balance at beginning of period 8.6 — 117.0 (0.2) 125.4 Balance at end of period $ 10.0 $ 3.6 $ 127.2 $ — $ 140.8 WELBILT, INC. Consolid ating Statement of Cash Flows (Unaudited) (in millions) Three Months Ended March 31, 2020 Parent Guarantor Non- Consolidating Adjustments Consolidated Cash flows from operating activities Net cash (used in) provided by operating activities $ (69.7) $ (4.5) $ 1.7 $ — $ (72.5) Cash flows from investing activities Capital expenditures — (4.5) (1.1) — (5.6) Intercompany investment — 7.6 (7.1) (0.5) — Other (3.9) — — — (3.9) Net cash (used in) provided by investing activities (3.9) 3.1 (8.2) (0.5) (9.5) Cash flows from financing activities Proceeds from long-term debt 128.0 — — — 128.0 Repayments on long-term debt and finance leases (23.0) (0.2) (0.1) — (23.3) Exercises of stock options 1.1 — — — 1.1 Payments on tax withholdings for equity awards (0.7) — — — (0.7) Intercompany financing (0.5) — — 0.5 — Net cash provided by (used in) financing activities 104.9 (0.2) (0.1) 0.5 105.1 Effect of exchange rate changes on cash — — (5.3) — (5.3) Net increase (decrease) in cash and cash equivalents and restricted cash 31.3 (1.6) (11.9) — 17.8 Balance at beginning of period 10.7 0.7 119.3 — 130.7 Balance at end of period $ 42.0 $ (0.9) $ 107.4 $ — $ 148.5

Business and Organization (Deta

Business and Organization (Details) distributor in Thousands	3 Months Ended
	Mar. 31, 2021segmentdistributormanufacturing_facility
Accounting Policies [Abstract]
Number of manufacturing facilities operating globally | manufacturing_facility	19
Number of distributors, dealers, buying groups and manufacturers' representatives (over) | distributor	5
Number of business segments | segment	3

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Government assistance in the form of cash, cost abatements and retention credits	$ 1.8
Receivable related to government assistance	$ 1.9

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Government Assistance (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Unusual or Infrequent Item, or Both [Line Items]
Government assistance received in the form of cash, cost abatements and retention credits	$ 1.2
Inventories
Unusual or Infrequent Item, or Both [Line Items]
Government assistance received in the form of cash, cost abatements and retention credits	0.6	$ 1.9
Cost of sales
Unusual or Infrequent Item, or Both [Line Items]
Government assistance received in the form of cash, cost abatements and retention credits	0.4
Selling, general and administrative expenses
Unusual or Infrequent Item, or Both [Line Items]
Government assistance received in the form of cash, cost abatements and retention credits	$ 0.8

Inventories - Net (Details)

Inventories - Net (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Inventories — net:
Raw materials	$ 92.5	$ 85.6
Work-in-process	14.9	13.9
Finished goods	100.1	85.4
Total inventories at FIFO cost	207.5	184.9
LIFO Reserve	(4.3)	(4.3)
Inventories — net	$ 203.2	$ 180.6

Property, Plant and Equipment_3

Property, Plant and Equipment - Net (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment
Total cost	$ 430.4	$ 430.2
Less accumulated depreciation	(300.8)	(301.1)
Total property, plant and equipment — net	129.6	129.1
Land
Property, Plant and Equipment
Total cost	9.7	9.7
Building and improvements
Property, Plant and Equipment
Total cost	100.6	99.8
Machinery, equipment and tooling
Property, Plant and Equipment
Total cost	231.2	231.7
Furniture and fixtures
Property, Plant and Equipment
Total cost	8.1	8.1
Computer hardware and software for internal use
Property, Plant and Equipment
Total cost	67.6	66.8
Construction in progress
Property, Plant and Equipment
Total cost	$ 13.2	$ 14.1

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Net - Narrative (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2020	Mar. 31, 2021
Trademarks and trade names
Indefinite-lived Intangible Assets [Line Items]
Impairment charges, indefinite-lived		$ 11,100,000
Net Book Value, indefinite-lived		212,000,000	$ 209,000,000
Trademarks and trade names | Americas
Indefinite-lived Intangible Assets [Line Items]
Net Book Value, indefinite-lived		130,600,000	130,600,000
Trademarks and trade names | EMEA
Indefinite-lived Intangible Assets [Line Items]
Net Book Value, indefinite-lived		73,600,000	70,800,000
Trademarks and trade names | APAC
Indefinite-lived Intangible Assets [Line Items]
Net Book Value, indefinite-lived		$ 7,800,000	$ 7,600,000
EMEA
Indefinite-lived Intangible Assets [Line Items]
Impairment charges, indefinite-lived	$ 11,100,000
APAC
Indefinite-lived Intangible Assets [Line Items]
Impairment charges, indefinite-lived	$ 0

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Net - Changes in the Carrying Amount of Goodwill by Geographic Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2018
Goodwill [Roll Forward]
Beginning net balance	$ 942.9
Foreign currency impact	(4.4)
Ending net balance	938.5
Goodwill, accumulated impairment loss		$ 515.7
Americas
Goodwill [Roll Forward]
Beginning net balance	832.6
Foreign currency impact	0
Ending net balance	832.6
Goodwill, accumulated impairment loss		312.2
EMEA
Goodwill [Roll Forward]
Beginning net balance	89.3
Foreign currency impact	(4.3)
Ending net balance	85
Goodwill, accumulated impairment loss		$ 203.5
APAC
Goodwill [Roll Forward]
Beginning net balance	21
Foreign currency impact	(0.1)
Ending net balance	$ 20.9

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Net - Gross Carrying Amount and Accumulated Amortization of Finite-Lived Intangible Assets other than Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2021
Intangible asset balances by major asset class
Gross Carrying Amount, Total	$ 881.1	$ 862.1
Accumulated Amortization Amount, finite-lived	(400.4)	(408.8)
Impairment Charges	(11.1)
Net Book Value, Total	469.6	453.3
Customer relationships
Intangible asset balances by major asset class
Gross Carrying Amount, finite-lived	479.1	476.4
Accumulated Amortization Amount	0	(0.2)
Accumulated Amortization Amount, finite-lived	(271.6)	(277.5)
Impairment Charges, finite-lived	0
Net Book Value, finite-lived	207.5	198.9
Other intangibles
Intangible asset balances by major asset class
Gross Carrying Amount, finite-lived	173.1	170.7
Accumulated Amortization Amount, finite-lived	(126.6)	(128.8)
Impairment Charges, finite-lived	0
Net Book Value, finite-lived	46.5	41.9
Patents
Intangible asset balances by major asset class
Gross Carrying Amount, finite-lived	5.8	5.8
Accumulated Amortization Amount, finite-lived	(2.2)	(2.3)
Impairment Charges, finite-lived	0
Net Book Value, finite-lived	3.6	3.5
Trademarks and trade names
Intangible asset balances by major asset class
Gross Carrying Amount, indefinite-lived	223.1	209.2
Impairment Charges, indefinite-lived	(11.1)
Net Book Value, indefinite-lived	$ 212	$ 209

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Miscellaneous accrued expenses	$ 38.5	$ 37.5
Employee related expenses	32.6	35.6
Accrued rebates and commissions	28.3	40.1
Current portion of operating lease liabilities	9.3	9.7
Interest payable	6	16.1
Customer deposits	5	3.9
Non-income taxes payable	3.6	3.6
Restructuring liabilities	3.2	4
Deferred revenues	2.9	2.9
Pension and postretirement health liabilities	2.1	2.1
Business Transformation Program related expenses	1.5	0.8
Product liabilities	1.5	1.7
Income and other taxes payable	1	5.6
Derivative liabilities	0.4	0.6
Total accrued expenses and other liabilities	$ 135.9	$ 164.2

Income Taxes (Details)

Income Taxes (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021USD ($)segment	Mar. 31, 2020USD ($)	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Income tax provision	$ 1.9	$ (0.2)
Effective tax rate	19.40%	1.30%
U.S. federal statutory rate	21.00%
Discrete tax expense (benefit)		$ 4.6
Number of reportable segments | segment	3
Unrecognized tax benefits	$ 9.8		$ 9.9
Prepaids and other current assets
Income Tax Contingency [Line Items]
Income taxes receivables	27.1		$ 27.4
Minimum
Income Tax Contingency [Line Items]
Unrecognized tax benefits reasonably possible to impact effective income tax rate	1.6
Maximum
Income Tax Contingency [Line Items]
Unrecognized tax benefits reasonably possible to impact effective income tax rate	$ 2

Debt - Schedule of Outstanding

Debt - Schedule of Outstanding Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Debt Instrument [Line Items]
Carrying Value, finance leases	$ 2		$ 2.2
Total debt and finance leases, including current portion	1,462		1,425.2
Less: Current portion of finance leases	(1.1)		(1)
Less: Unamortized debt issuance costs	(15.7)		(16.7)
Less: Hedge accounting fair value adjustment	0.3		0.3
Total long-term debt and finance leases	$ 1,445.5		$ 1,407.8
Weighted Average Interest Rate, finance leases	4.63%		4.80%
Outstanding debt issuance costs, net of amortization	$ 19		$ 20.3
Debt issuance costs, revolving credit facility	3.3		3.6
Amortization of debt issuance costs	(1.3)	$ (1.1)
Adjustment | Other Income (Expense)
Debt Instrument [Line Items]
Amortization of debt issuance costs		$ 1.1
Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Value, long-term debt	$ 180		$ 143
Weighted Average Interest Rate, long-term debt	4.44%		4.21%
Term Loan B Facility
Debt Instrument [Line Items]
Carrying Value, long-term debt	$ 855		$ 855
Weighted Average Interest Rate, long-term debt	2.96%		3.45%
9.50% Senior Notes due 2024
Debt Instrument [Line Items]
Carrying Value, long-term debt	$ 425		$ 425
Stated interest rate	9.50%
Weighted Average Interest Rate, long-term debt	9.72%		9.72%

Debt - Narrative (Details)

Debt - Narrative (Details)	1 Months Ended	3 Months Ended
	Apr. 30, 2020USD ($)	Jun. 30, 2020	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Mar. 31, 2016USD ($)
2016 Credit Facility
Debt Instrument [Line Items]
Balance outstanding			$ 180,000,000	$ 143,000,000
2016 Credit Facility | Line of credit
Debt Instrument [Line Items]
Credit facility capacity					$ 1,300,000,000
2016 Credit Facility | Line of credit | Term Loan B Facility
Debt Instrument [Line Items]
Credit facility capacity					900,000,000
2016 Credit Facility | Line of credit | Revolving Credit Facility
Debt Instrument [Line Items]
Credit facility capacity					$ 400,000,000
Maximum pro forma senior secured leverage ratio					3.75
Available borrowings			213,400,000
2016 Credit Facility | Line of credit | Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Spread on variable interest rate		2.50%
2016 Credit Facility | Line of credit | Revolving Credit Facility | Base Rate
Debt Instrument [Line Items]
Spread on variable interest rate		1.50%
2016 Credit Facility | Line of credit | Letters of Credit
Debt Instrument [Line Items]
Credit facility capacity					$ 30,000,000
Balance outstanding			6,600,000
2016 Credit Facility | Line of credit | Incremental Revolving or Term Loan Facilities
Debt Instrument [Line Items]
Credit facility capacity					$ 275,000,000
Amended 2016 Credit Agreement | Line of credit | Revolving Credit Facility
Debt Instrument [Line Items]
Term to comply with financial covenants	90 days
Cash balance limit	$ 100,000,000
Term to use cash in excess of draw restriction	10 days
Carve-out restriction for general investments	$ 25,000,000
Quarterly fee	0.50%
Debt issuance cost	$ 2,100,000
Other Letters of Credit | Other outstanding letters of credit or guarantees of payment | Letters of Credit
Debt Instrument [Line Items]
Balance outstanding			$ 1,300,000

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) € in Millions, $ in Millions	1 Months Ended		3 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2017EUR (€)	Mar. 31, 2021USD ($)
Derivative [Line Items]
Cash flow hedge, gain (loss) to be reclassified in next twelve months			$ 0.4
Minimum length of time hedged in cash flow hedge			15 months
Maximum length of time hedged in cash flow hedge			36 months
Designated as Hedging Instrument | Cross-currency interest rate swap contract
Derivative [Line Items]
Derivative notional amount (USD and EUR) | €		€ 50
Term of derivative contract		3 years
Payments for derivative instrument	$ 4.1
Interest Rate Swap, March 2019 | Designated as Hedging Instrument | Interest rate swap contracts
Derivative [Line Items]
Derivative notional amount (USD and EUR)	$ 425

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Currency Forward Contracts (Details) - Foreign currency exchange contracts € in Millions, £ in Millions, SFr in Millions, $ in Millions, $ in Millions, $ in Millions	Mar. 31, 2021CAD ($)	Mar. 31, 2021EUR (€)	Mar. 31, 2021GBP (£)	Mar. 31, 2021MXN ($)	Mar. 31, 2021SGD ($)	Mar. 31, 2021CHF (SFr)	Dec. 31, 2020CAD ($)	Dec. 31, 2020EUR (€)	Dec. 31, 2020GBP (£)	Dec. 31, 2020MXN ($)	Dec. 31, 2020SGD ($)	Dec. 31, 2020CHF (SFr)
Designated as Hedging Instrument
Derivative [Line Items]
Derivative notional amount	$ 9.2	€ 5.1	£ 3.2	$ 92.4	$ 2.3		$ 6.4	€ 3.3	£ 6.1	$ 92.8	$ 2.3
Other Operating Income (Expense) | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative notional amount	$ 1.8	€ 82.7	£ 22.5	$ 20.9	$ 0.6	SFr 7	$ 1.1	€ 84.2	£ 1	$ 13.8	$ 0.3	SFr 7

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of Impact of Derivative Instruments on the Consolidated Statements of Comprehensive Income and Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	$ (0.2)	$ (1.1)
Pretax gain/(loss) reclassified from AOCI into income	0.4	(0.6)
Foreign currency exchange contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	(0.2)	(1.1)
Commodity contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	0	0
Cost of sales | Foreign currency exchange contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	0.4	(0.1)
Cost of sales | Commodity contracts
Derivative [Line Items]
Pretax gain/(loss) reclassified from AOCI into income	0	(0.5)
Designated as Hedging Instrument | Net Investment Hedging | Interest rate swap contracts
Derivative [Line Items]
Pretax gain/(loss) recognized in AOCI	0	(0.8)
Gain/(loss) reclassified from AOCI into income	0	0
Designated as Hedging Instrument | Net Investment Hedging | Other (income) expense — net | Interest rate swap contracts
Derivative [Line Items]
Gain/(loss) recognized in income (amount excluded from effectiveness testing)	$ 0	$ 0.3

Derivative Financial Instrume_6

Derivative Financial Instruments - Effects of Derivative Financial Instruments on Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Cost of Sales	$ 199	$ 214.1
Interest Expense	18.7	22.4
Amount of gain/(loss) reclassified from AOCI into income	0.4	(0.6)
Interest rate contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on hedged item	0	0
Interest rate contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on hedged item	0	0.1
Foreign currency exchange contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	0.4	(0.1)
Foreign currency exchange contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	0	0
Commodity contracts | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	0	(0.5)
Commodity contracts | Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) reclassified from AOCI into income	$ 0	$ 0

Derivative Financial Instrume_7

Derivative Financial Instruments - Schedule of Outstanding Commodity Contracts (Details) - Not Designated as Hedging Instrument	12 Months Ended
	Dec. 31, 2020t
Aluminum
Derivative [Line Items]
Commodity units hedged, mass	35
Copper
Derivative [Line Items]
Commodity units hedged, mass	18

Derivative Financial Instrume_8

Derivative Financial Instruments - Location and Effects on Consolidated Statements of Operations of Derivative Instruments Not Designated as Hedging Instruments (Details) - Not Designated as Hedging Instrument - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Foreign currency exchange contracts | Other (income) expense — net
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, gain (loss) on derivative, net	$ 2.5	$ (2)
Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, gain (loss) on derivative, net		$ (0.5)

Derivative Financial Instrume_9

Derivative Financial Instruments - Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Assets in the Accompanying Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Total asset derivatives	$ 1.3	$ 2
Designated as Hedging Instrument
Derivative [Line Items]
Total asset derivatives	0.6	1.1
Designated as Hedging Instrument | Prepaids and other current assets | Foreign currency exchange contracts
Derivative [Line Items]
Total asset derivatives	0.6	1.1
Not Designated as Hedging Instrument
Derivative [Line Items]
Total asset derivatives	0.7	0.9
Not Designated as Hedging Instrument | Prepaids and other current assets | Foreign currency exchange contracts
Derivative [Line Items]
Total asset derivatives	$ 0.7	$ 0.9

Derivative Financial Instrum_10

Derivative Financial Instruments - Schedule of the Fair Value of Outstanding Derivative Contracts Recorded as Liabilities in the Accompanying Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Total liability derivatives	$ 0.4	$ 0.6
Designated as Hedging Instrument
Derivative [Line Items]
Total liability derivatives	0.2	0.2
Designated as Hedging Instrument | Accrued expenses and other liabilities | Foreign currency exchange contracts
Derivative [Line Items]
Total liability derivatives	0.2	0.2
Not Designated as Hedging Instrument
Derivative [Line Items]
Total liability derivatives	0.2	0.4
Not Designated as Hedging Instrument | Accrued expenses and other liabilities | Foreign currency exchange contracts
Derivative [Line Items]
Total liability derivatives	$ 0.2	$ 0.4

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Senior Notes
Financial assets and liabilities accounted for at fair value on a recurring basis
Fair value of debt	$ 438.3	$ 439.9
Term Loan B Facility | Secured Debt
Financial assets and liabilities accounted for at fair value on a recurring basis
Fair value of debt	$ 822.4	$ 814.9

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis by Level within the Fair Value Hierarchy (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	$ 1.3	$ 2
Total assets at fair value	1.3	2
Total current liabilities at fair value	0.4	0.6
Total liabilities at fair value	0.4	0.6
Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	1.3	2
Total current liabilities at fair value	0.4	0.6
Level 1
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	0	0
Total assets at fair value	0	0
Total current liabilities at fair value	0	0
Total liabilities at fair value	0	0
Level 1 | Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	0	0
Total current liabilities at fair value	0	0
Level 2
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	1.3	2
Total assets at fair value	1.3	2
Total current liabilities at fair value	0.4	0.6
Total liabilities at fair value	0.4	0.6
Level 2 | Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	1.3	2
Total current liabilities at fair value	0.4	0.6
Level 3
Financial assets and liabilities accounted for at fair value on a recurring basis
Total current assets at fair value	0	0
Total assets at fair value	0	0
Total current liabilities at fair value	0	0
Total liabilities at fair value	0	0
Level 3 | Foreign currency exchange contracts
Financial assets and liabilities accounted for at fair value on a recurring basis
Derivative assets, current	0	0
Total current liabilities at fair value	$ 0	$ 0

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Inputs and Valuation Techniques (Details) - Fair Value, Nonrecurring - Level 3	3 Months Ended
	Mar. 31, 2021
Long Term Growth Rate
Financial assets and liabilities accounted for at fair value on a recurring basis
Finite-lived intangible assets, measurement input	2.00%
Discount Rate
Financial assets and liabilities accounted for at fair value on a recurring basis
Finite-lived intangible assets, measurement input	12.00%
Pre-Tax Royalty Rate | Minimum
Financial assets and liabilities accounted for at fair value on a recurring basis
Finite-lived intangible assets, measurement input	1.50%
Pre-Tax Royalty Rate | Maximum
Financial assets and liabilities accounted for at fair value on a recurring basis
Finite-lived intangible assets, measurement input	2.25%

Contingencies and Significant_2

Contingencies and Significant Estimates (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Warranty claims expected to be paid	$ 39.6	$ 39.9
Product liability reserves	1.5	1.7
Product liability reserves for specific cases	0.7	0.9
Product liability reserves for claims incurred but not reported	0.8
Reserve for environmental matters	$ 0.5	0.8
Estimate of possible loss		$ 3.1	$ 3.1

Product Warranties - Narrative

Product Warranties - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Product Warranty Liability [Line Items]
Standard product warranty period, low end of range	12 months
Standard product warranty period, high end of range	60 months
Short-term portion of deferred revenue	$ 2.9	$ 2.9
Accrued expenses and other liabilities
Product Warranty Liability [Line Items]
Short-term portion of deferred revenue	1.9	1.9
Other long-term liabilities
Product Warranty Liability [Line Items]
Long-term portion of deferred revenue	$ 3.5	$ 3.5

Product Warranties - Schedule o

Product Warranties - Schedule of the Summary of Product Warranty Activity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Warranty activity
Balance at beginning of period	$ 39.9
Additions for issuance of warranties	6.5
Settlements (in cash or in kind)	(6.8)
Balance at end of period	39.6
Other long-term liabilities
Product Warranty Liability [Line Items]
Long-term product warranty liabilities	$ 10.2	$ 10

Employee Benefit Plans - Compon

Employee Benefit Plans - Components of Period Benefits Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost of projected benefit obligations	$ 0.6	$ 1
Expected return on assets	(0.8)	(1)
Amortization of prior service cost	0	0
Amortization of actuarial net loss	0.7	0.6
Net periodic benefit cost	0.5	0.6
Postretirement Health and Other Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost of projected benefit obligations	0.1	0
Expected return on assets	0	0
Amortization of prior service cost	(0.1)	(0.1)
Amortization of actuarial net loss	0.2	0.2
Net periodic benefit cost	$ 0.2	$ 0.1

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) $ in Millions	Mar. 31, 2021USD ($)
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Minimum pension contribution per the American Rescue Plan of 2021, amount	$ 6.5

Business Transformation Progr_3

Business Transformation Program and Restructuring - Transformation Program Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Schedule Of Business Transformation Program Costs [Line Items]
Transformation Program expense	$ 2.2	$ 11.6
Cost of sales
Schedule Of Business Transformation Program Costs [Line Items]
Transformation Program expense	0.5	0.8
Selling, general and administrative expenses
Schedule Of Business Transformation Program Costs [Line Items]
Transformation Program expense	$ 1.7	$ 10.8

Business Transformation Progr_4

Business Transformation Program and Restructuring - Rollforward of all Restructuring Activities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Rollforward of all restructuring activities
Beginning balance	$ 11.2
Restructuring activities	0.2	$ 3.7
Cash payments	(1.3)
Ending balance	10.1
Workforce reductions | 2021 Plans
Rollforward of all restructuring activities
Beginning balance	0
Restructuring activities	0.1
Cash payments	0
Ending balance	0.1
Workforce reductions | 2020 Plans
Rollforward of all restructuring activities
Restructuring activities		2.8
Workforce reductions | 2019 Plans
Rollforward of all restructuring activities
Restructuring activities		$ 0.8
Pension withdrawal obligation | 2020 Plans
Rollforward of all restructuring activities
Beginning balance	2.4
Restructuring activities	0
Cash payments	(0.9)
Ending balance	1.5
Pension withdrawal obligation | 2019 Plans
Rollforward of all restructuring activities
Beginning balance	0.2
Restructuring activities	0.1
Cash payments	(0.1)
Ending balance	0.2
Pension withdrawal obligation | 2018 and Previous Plans
Rollforward of all restructuring activities
Beginning balance	8.6
Restructuring activities	0
Cash payments	(0.3)
Ending balance	$ 8.3

Business Transformation Progr_5

Business Transformation Program and Restructuring - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Current portion of liability	$ 3.2			$ 4
Long term-portion of liability	6.9			$ 7.2
Restructuring activities	0.2	$ 3.7
SWEDEN | Operating Segments | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.1
SWEDEN | Operating Segments | Workforce reductions | Forecast
Restructuring Cost and Reserve [Line Items]
Restructuring activities			$ 0.8
EMEA | Operating Segments | Workforce reductions | Forecast
Restructuring Cost and Reserve [Line Items]
Restructuring activities			$ 0.9
Americas | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0	2.2
2020 Operating Expense Reduction and Improved Efficiencies | Americas | Operating Segments | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities	$ 0.1	2.2
2020 Operating Expense Reduction and Improved Efficiencies | Corporate Segment | Operating Segments | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities		0.6
2020 Plans | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities		2.8
2019 Plans | Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring activities		0.8
2019 Plans | Accelerated Depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring activities		$ 0.1

Business Transformation Progr_6

Business Transformation Program and Restructuring - Restructuring Expense (Recovery) by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring activities	$ 0.2	$ 3.7
Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0	0.1
Restructuring and other expense
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.2	3.6
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0	0.7
Americas | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0	2.2
EMEA | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	0.1	0.3
APAC | Operating Segments
Restructuring Cost and Reserve [Line Items]
Restructuring activities	$ 0.1	$ 0.5

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Components of AOCI (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	$ 277.6	$ 273	$ 213.4	$ 253.4	[1]
Foreign Currency Translation
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	12	19.1	(32.5)	(4.3)
Tax expense (benefit)	(1.4)	(1.4)
Gains and Losses on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	(0.5)	0	(2)	(1.6)
Tax expense (benefit)	1	1.1
Pension & Postretirement
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	(38.2)	(38.6)	(33.6)	(35.6)
Tax expense (benefit)	(6.4)	(6.6)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total accumulated other comprehensive loss	$ (26.7)	$ (19.5)	$ (68.1)	$ (41.5)	[1]
[1]	(1) As of December 31, 2019, the Company reclassified a portion of the liability within the Welbilt Deferred Compensation Plan totaling $0.4 million from "Other long-term liabilities" to "Treasury stock" to properly net the liability with the corresponding Welbilt common stock owned by the Deferred Compensation Plan. See further discussion in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Reconciliations for the Changes in AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 273	$ 253.4	[1]
Other comprehensive (loss) income before reclassifications	(7.5)	(27.2)
Reclassifications	0.4	1.3
Tax effect of reclassifications	(0.1)	(0.7)
Total other comprehensive loss, net of tax	(7.2)	(26.6)
Ending balance	277.6	213.4
Foreign Currency Translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	19.1	(4.3)
Other comprehensive (loss) income before reclassifications	(7.1)	(27.5)
Reclassifications	0	0
Tax effect of reclassifications	0	(0.7)
Total other comprehensive loss, net of tax	(7.1)	(28.2)
Ending balance	12	(32.5)
Gains and Losses on Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0	(1.6)
Other comprehensive (loss) income before reclassifications	(0.2)	(1.1)
Reclassifications	(0.4)	0.6
Tax effect of reclassifications	0.1	0.1
Total other comprehensive loss, net of tax	(0.5)	(0.4)
Ending balance	(0.5)	(2)
Pension & Postretirement
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(38.6)	(35.6)
Other comprehensive (loss) income before reclassifications	(0.2)	1.4
Reclassifications	0.8	0.7
Tax effect of reclassifications	(0.2)	(0.1)
Total other comprehensive loss, net of tax	0.4	2
Ending balance	(38.2)	(33.6)
Total
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(19.5)	(41.5)	[1]
Total other comprehensive loss, net of tax	(7.2)	(26.6)
Ending balance	$ (26.7)	$ (68.1)
[1]	(1) As of December 31, 2019, the Company reclassified a portion of the liability within the Welbilt Deferred Compensation Plan totaling $0.4 million from "Other long-term liabilities" to "Treasury stock" to properly net the liability with the corresponding Welbilt common stock owned by the Deferred Compensation Plan. See further discussion in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.

Accumulated Other Comprehensi_5

Accumulated Other Comprehensive Loss - Reclassifications (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ (199)	$ (214.1)
Earnings (loss) before income taxes	9.8	(15.3)
Tax effect	(1.9)	0.2
Net loss	7.9	(15.1)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net loss	0.2	(1.1)
Reclassification out of Accumulated Other Comprehensive Income | Gains (losses) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Earnings (loss) before income taxes	0.4	(0.6)
Tax effect	(0.1)	0.1
Net loss	0.3	(0.5)
Reclassification out of Accumulated Other Comprehensive Income | Amortization of prior service cost
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Earnings (loss) before income taxes	0.1	0.1
Reclassification out of Accumulated Other Comprehensive Income | Actuarial losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Earnings (loss) before income taxes	(0.9)	(0.8)
Reclassification out of Accumulated Other Comprehensive Income | Amortization of pension and postretirement items
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Earnings (loss) before income taxes	(0.8)	(0.7)
Tax effect	0.7	0.1
Net loss	(0.1)	(0.6)
Reclassification out of Accumulated Other Comprehensive Income | Foreign currency exchange contracts | Gains (losses) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	0.4	(0.1)
Reclassification out of Accumulated Other Comprehensive Income | Commodity contracts | Gains (losses) on cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 0	$ (0.5)

Earnings (Loss) Per Share - Com

Earnings (Loss) Per Share - Components of Basic and Diluted Shares (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average shares outstanding — Basic (in shares)	141,622,281	141,430,614
Effect of dilutive securities:
Total effect of dilutive securities (in shares)	566,831	0
Weighted average shares outstanding — Diluted (in shares)	142,189,112	141,430,614
Stock options
Effect of dilutive securities:
Effect of dilutive securities (in shares)	70,226	0
Unvested restricted stock units
Effect of dilutive securities:
Effect of dilutive securities (in shares)	496,605	0

Earnings (Loss) Per Share - Nar

Earnings (Loss) Per Share - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Total potential shares of common stock (in shares)	900,000	3,639,747

Earnings (Loss) Per Share - Ant

Earnings (Loss) Per Share - Antidilutive Shares (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock (in shares)	900,000	3,639,747
Performance target achievement (in percent)	100.00%
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock (in shares)		2,372,495
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock (in shares)		575,758
Unvested performance share units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potential shares of common stock (in shares)		691,494
Vesting period	3 years
Unvested performance share units | Minimum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Vesting percentage	0.00%
Unvested performance share units | Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Vesting percentage	200.00%

Business Segments - Financial I

Business Segments - Financial Information by Segment (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021USD ($)segment	Mar. 31, 2020USD ($)
Segment Reporting Information [Line Items]
Number of business segments | segment	3
Segment Adjusted Operating EBITDA:
Total net sales	$ 316.8	$ 328.9
Amortization expense	(10.5)	(10)
Depreciation expense	(5.4)	(5.2)
Transaction costs	0	(0.1)
Other items	0	(3.1)
Transformation Program expense	(2.2)	(11.6)
Restructuring activities	(0.2)	(3.7)
Loss from impairment and disposal of assets — net	0	(11.2)
Earnings from operations	31.5	0.6
Interest expense	(18.7)	(22.4)
Other (expense) income — net	(3)	6.5
Earnings (loss) before income taxes	9.8	(15.3)
Fair value inventory adjustments		0.2
Professional services and other direct acquisition and integration costs	0.1	0.3
Selling, general and administrative expenses
Segment Adjusted Operating EBITDA:
Transaction costs	(0.1)
Transformation Program expense	(1.7)	(10.8)
Operating Segments
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	71.7	74.1
Elimination of intersegment sales
Segment Adjusted Operating EBITDA:
Total net sales	(71.7)	(62.9)
Corporate and unallocated expenses
Segment Adjusted Operating EBITDA:
Total Segment Adjusted Operating EBITDA	(21.9)	(28.6)
Americas
Segment Adjusted Operating EBITDA:
Total net sales	221	218.1
Americas | Operating Segments
Segment Adjusted Operating EBITDA:
Total net sales	246.4	250.5
Total Segment Adjusted Operating EBITDA	$ 50.3	$ 52.3
Americas | Operating Segments | Geographic Concentration Risk | EBITDA
Segment Adjusted Operating EBITDA:
Adjusted Operating EBITDA % by segment	20.40%	20.90%
EMEA
Segment Adjusted Operating EBITDA:
Total net sales	$ 61	$ 71.6
EMEA | Operating Segments
Segment Adjusted Operating EBITDA:
Total net sales	93.4	90
Total Segment Adjusted Operating EBITDA	$ 14.6	$ 13.6
EMEA | Operating Segments | Geographic Concentration Risk | EBITDA
Segment Adjusted Operating EBITDA:
Adjusted Operating EBITDA % by segment	15.60%	15.10%
APAC
Segment Adjusted Operating EBITDA:
Total net sales	$ 34.8	$ 39.2
APAC | Operating Segments
Segment Adjusted Operating EBITDA:
Total net sales	48.7	51.3
Total Segment Adjusted Operating EBITDA	$ 6.8	$ 8.2
APAC | Operating Segments | Geographic Concentration Risk | EBITDA
Segment Adjusted Operating EBITDA:
Adjusted Operating EBITDA % by segment	14.00%	16.00%

Business Segments - Revenue by

Business Segments - Revenue by Major Source and Geographic Location (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Disaggregation of Revenue [Line Items]
Total net sales	$ 316.8	$ 328.9
Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	261.3	270
Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	55.5	58.9
Americas
Disaggregation of Revenue [Line Items]
Total net sales	221	218.1
Americas | Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	182.3	182
Americas | Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	38.7	36.1
EMEA
Disaggregation of Revenue [Line Items]
Total net sales	61	71.6
EMEA | Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	51.1	56
EMEA | Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	9.9	15.6
APAC
Disaggregation of Revenue [Line Items]
Total net sales	34.8	39.2
APAC | Commercial Foodservice Equipment
Disaggregation of Revenue [Line Items]
Total net sales	27.9	32
APAC | Aftermarket Parts and Support
Disaggregation of Revenue [Line Items]
Total net sales	6.9	7.2
United States
Disaggregation of Revenue [Line Items]
Total net sales	206.4	204.4
Other Americas
Disaggregation of Revenue [Line Items]
Total net sales	16.9	18.5
EMEA
Disaggregation of Revenue [Line Items]
Total net sales	58.9	69.2
APAC
Disaggregation of Revenue [Line Items]
Total net sales	$ 34.6	$ 36.8

Business Segments - Total Asset

Business Segments - Total Assets by Segment (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total assets	$ 2,165.5	$ 2,141.6
Operating Segments | Americas
Segment Reporting Information [Line Items]
Total assets	1,512.7	1,488
Operating Segments | EMEA
Segment Reporting Information [Line Items]
Total assets	342.3	347.6
Operating Segments | APAC
Segment Reporting Information [Line Items]
Total assets	205.5	209
Corporate
Segment Reporting Information [Line Items]
Total assets	$ 105	$ 97

Subsidiary Guarantors and Sen_3

Subsidiary Guarantors and Senior Notes - Statement of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Condensed Income Statements, Captions [Line Items]
Net sales	$ 316.8	$ 328.9
Cost of sales	199	214.1
Gross profit	117.8	114.8
Selling, general and administrative expenses	76	86.5
Amortization expense	10.1	9.7
Restructuring and other expense	0.2	6.8
Loss from impairment and disposal of assets — net	0	11.2
(Loss) earnings from operations	31.5	0.6
Interest expense	18.7	22.4
Other expense (income) — net	3	(6.5)
Equity in earnings (loss) of subsidiaries	0	0
Earnings (loss) before income taxes	9.8	(15.3)
Income tax expense (benefit)	1.9	(0.2)
Net loss	7.9	(15.1)
Total other comprehensive loss, net of tax	(7.2)	(26.6)
Comprehensive income (loss)	0.7	(41.7)
Reportable Legal Entities | Parent
Condensed Income Statements, Captions [Line Items]
Net sales	0	0
Cost of sales	0	0
Gross profit	0	0
Selling, general and administrative expenses	16.3	18.1
Amortization expense	0	0
Restructuring and other expense	0	0.7
Loss from impairment and disposal of assets — net		0
(Loss) earnings from operations	(16.3)	(18.8)
Interest expense	20.1	21.9
Other expense (income) — net	(16.2)	(5.2)
Equity in earnings (loss) of subsidiaries	32.5	5
Earnings (loss) before income taxes	12.3	(30.5)
Income tax expense (benefit)	(7.1)	(15.4)
Net loss	19.4	(15.1)
Total other comprehensive loss, net of tax	(7.2)	(26.6)
Comprehensive income (loss)	12.2	(41.7)
Reportable Legal Entities | Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Net sales	226.1	233.1
Cost of sales	163.5	170
Gross profit	62.6	63.1
Selling, general and administrative expenses	31.2	32.8
Amortization expense	7	7.1
Restructuring and other expense	0	4.8
Loss from impairment and disposal of assets — net		0
(Loss) earnings from operations	24.4	18.4
Interest expense	0.2	0.2
Other expense (income) — net	(5.4)	(6.3)
Equity in earnings (loss) of subsidiaries	9.7	(4.4)
Earnings (loss) before income taxes	39.3	20.1
Income tax expense (benefit)	6.8	15.1
Net loss	32.5	5
Total other comprehensive loss, net of tax	(7.5)	(25)
Comprehensive income (loss)	25	(20)
Reportable Legal Entities | Non- Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Net sales	195.7	210.9
Cost of sales	140.5	159.2
Gross profit	55.2	51.7
Selling, general and administrative expenses	28.5	35.6
Amortization expense	3.1	2.6
Restructuring and other expense	0.2	1.3
Loss from impairment and disposal of assets — net		11.2
(Loss) earnings from operations	23.4	1
Interest expense	(1.6)	0.3
Other expense (income) — net	13.1	5
Equity in earnings (loss) of subsidiaries	0	0
Earnings (loss) before income taxes	11.9	(4.3)
Income tax expense (benefit)	2.2	0.1
Net loss	9.7	(4.4)
Total other comprehensive loss, net of tax	(7.2)	(24.6)
Comprehensive income (loss)	2.5	(29)
Consolidating Adjustments
Condensed Income Statements, Captions [Line Items]
Net sales	(105)	(115.1)
Cost of sales	(105)	(115.1)
Gross profit	0	0
Selling, general and administrative expenses	0	0
Amortization expense	0	0
Restructuring and other expense	0	0
Loss from impairment and disposal of assets — net		0
(Loss) earnings from operations	0	0
Interest expense	0	0
Other expense (income) — net	11.5	0
Equity in earnings (loss) of subsidiaries	(42.2)	(0.6)
Earnings (loss) before income taxes	(53.7)	(0.6)
Income tax expense (benefit)	0	0
Net loss	(53.7)	(0.6)
Total other comprehensive loss, net of tax	14.7	49.6
Comprehensive income (loss)	$ (39)	$ 49

Subsidiary Guarantors and Sen_4

Subsidiary Guarantors and Senior Notes - Balance Sheets (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019	[1]
Current assets:
Cash and cash equivalents	$ 140.3	$ 125
Restricted cash	0.5	0.4
Accounts receivable — net	174.5	165.9
Inventories — net	203.2	180.6
Prepaids and other current assets	49.9	50.1
Total current assets	568.4	522
Property, plant and equipment — net	129.6	129.1
Operating lease right-of-use assets	45.7	47.5
Goodwill	938.5	942.9
Other intangible assets — net	453.3	469.6
Intercompany long-term notes receivable	0	0
Due from affiliates	0	0
Investment in subsidiaries	0	0
Other non-current assets	30	30.5
Total assets	2,165.5	2,141.6
Current liabilities:
Trade accounts payable	102.2	86.4
Accrued expenses and other liabilities	135.9	164.2
Current portion of long-term debt and finance leases	1.1	1
Product warranties	29.4	29.9
Total current liabilities	268.6	281.5
Total long-term debt and finance leases	1,445.5	1,407.8
Deferred income taxes	74.9	76.5
Pension and postretirement health liabilities	25.3	27.8
Intercompany long-term notes payable	0	0
Due to affiliates	0	0
Investment in subsidiaries	0	0
Operating lease liabilities	36.5	37.7
Other long-term liabilities	37.1	37.3
Total non-current liabilities	1,619.3	1,587.1
Total equity	277.6	273	$ 213.4	$ 253.4
Total liabilities and equity	2,165.5	2,141.6
Reportable Legal Entities | Parent
Current assets:
Cash and cash equivalents	10	8.6
Restricted cash	0	0
Accounts receivable — net	0.3	0.4
Inventories — net	0	0
Prepaids and other current assets	24.6	24.2
Total current assets	34.9	33.2
Property, plant and equipment — net	14.3	14.2
Operating lease right-of-use assets	2.2	2.2
Goodwill	0	0
Other intangible assets — net	0.2	0.2
Intercompany long-term notes receivable	0	0
Due from affiliates	0	0
Investment in subsidiaries	4,518.4	4,485.8
Other non-current assets	8.9	8.3
Total assets	4,578.9	4,543.9
Current liabilities:
Trade accounts payable	0	0
Accrued expenses and other liabilities	20.3	33.6
Current portion of long-term debt and finance leases	0	0
Product warranties	0	0
Total current liabilities	20.3	33.6
Total long-term debt and finance leases	1,444.6	1,406.7
Deferred income taxes	43.9	43.4
Pension and postretirement health liabilities	11.9	12.9
Intercompany long-term notes payable	5.8	15.7
Due to affiliates	2,759.9	2,743
Investment in subsidiaries	0	0
Operating lease liabilities	2	2.1
Other long-term liabilities	12.9	13.4
Total non-current liabilities	4,281	4,237.2
Total equity	277.6	273.1
Total liabilities and equity	4,578.9	4,543.9
Reportable Legal Entities | Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	3.6	0
Restricted cash	0	0
Accounts receivable — net	83.9	72
Inventories — net	109.7	83.4
Prepaids and other current assets	3.6	2.5
Total current assets	200.8	157.9
Property, plant and equipment — net	70.2	70.6
Operating lease right-of-use assets	3.5	3.9
Goodwill	832.5	832.4
Other intangible assets — net	308.2	315.6
Intercompany long-term notes receivable	5.8	5.8
Due from affiliates	3,490	3,509.9
Investment in subsidiaries	0	0
Other non-current assets	3.6	4.4
Total assets	4,914.6	4,900.5
Current liabilities:
Trade accounts payable	46.8	44
Accrued expenses and other liabilities	57.3	66.1
Current portion of long-term debt and finance leases	0.5	0.4
Product warranties	18.7	19.7
Total current liabilities	123.3	130.2
Total long-term debt and finance leases	0.2	0.3
Deferred income taxes	(0.7)	0
Pension and postretirement health liabilities	10.2	10.2
Intercompany long-term notes payable	0	0
Due to affiliates	0	0
Investment in subsidiaries	244.4	254.2
Operating lease liabilities	2.1	2.3
Other long-term liabilities	16.7	17.5
Total non-current liabilities	272.9	284.5
Total equity	4,518.4	4,485.8
Total liabilities and equity	4,914.6	4,900.5
Reportable Legal Entities | Non- Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	126.7	116.6
Restricted cash	0.5	0.4
Accounts receivable — net	90.3	93.5
Inventories — net	93.5	97.2
Prepaids and other current assets	21.9	23.4
Total current assets	332.9	331.1
Property, plant and equipment — net	45.1	44.3
Operating lease right-of-use assets	40	41.4
Goodwill	106	110.5
Other intangible assets — net	144.9	153.8
Intercompany long-term notes receivable	0	9.9
Due from affiliates	0	0
Investment in subsidiaries	0	0
Other non-current assets	17.5	17.8
Total assets	686.4	708.8
Current liabilities:
Trade accounts payable	55.6	42.5
Accrued expenses and other liabilities	58.3	64.5
Current portion of long-term debt and finance leases	0.6	0.6
Product warranties	10.7	10.2
Total current liabilities	125.2	117.8
Total long-term debt and finance leases	0.7	0.8
Deferred income taxes	31.7	33.1
Pension and postretirement health liabilities	3.2	4.7
Intercompany long-term notes payable	0	0
Due to affiliates	730.1	766.9
Investment in subsidiaries	0	0
Operating lease liabilities	32.4	33.3
Other long-term liabilities	7.5	6.4
Total non-current liabilities	805.6	845.2
Total equity	(244.4)	(254.2)
Total liabilities and equity	686.4	708.8
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	(0.2)
Restricted cash	0	0
Accounts receivable — net	0	0
Inventories — net	0	0
Prepaids and other current assets	(0.2)	0
Total current assets	(0.2)	(0.2)
Property, plant and equipment — net	0	0
Operating lease right-of-use assets	0	0
Goodwill	0	0
Other intangible assets — net	0	0
Intercompany long-term notes receivable	(5.8)	(15.7)
Due from affiliates	(3,490)	(3,509.9)
Investment in subsidiaries	(4,518.4)	(4,485.8)
Other non-current assets	0	0
Total assets	(8,014.4)	(8,011.6)
Current liabilities:
Trade accounts payable	(0.2)	(0.1)
Accrued expenses and other liabilities	0	0
Current portion of long-term debt and finance leases	0	0
Product warranties	0	0
Total current liabilities	(0.2)	(0.1)
Total long-term debt and finance leases	0	0
Deferred income taxes	0	0
Pension and postretirement health liabilities	0	0
Intercompany long-term notes payable	(5.8)	(15.7)
Due to affiliates	(3,490)	(3,509.9)
Investment in subsidiaries	(244.4)	(254.2)
Operating lease liabilities	0	0
Other long-term liabilities	0	0
Total non-current liabilities	(3,740.2)	(3,779.8)
Total equity	(4,274)	(4,231.7)
Total liabilities and equity	$ (8,014.4)	$ (8,011.6)
[1]	(1) As of December 31, 2019, the Company reclassified a portion of the liability within the Welbilt Deferred Compensation Plan totaling $0.4 million from "Other long-term liabilities" to "Treasury stock" to properly net the liability with the corresponding Welbilt common stock owned by the Deferred Compensation Plan. See further discussion in the Company's Annual Report on Form 10-K for the year ended December 31, 2020.

Subsidiary Guarantors and Sen_5

Subsidiary Guarantors and Senior Notes - Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net cash (used in) provided by operating activities	$ (16.4)	$ (72.5)
Cash flows from investing activities
Capital expenditures	(4.7)	(5.6)
Intercompany investment	0	0
Other	0	(3.9)
Net cash used in investing activities	(4.7)	(9.5)
Cash flows from financing activities
Proceeds from long-term debt	58	128
Repayments on long-term debt and finance leases	(21.3)	(23.3)
Exercises of stock options	0.5	1.1
Payments on tax withholdings for equity awards	(0.1)	(0.7)
Intercompany financing	0	0
Net cash provided by financing activities	37.1	105.1
Effect of exchange rate changes on cash	(0.6)	(5.3)
Net increase in cash and cash equivalents and restricted cash	15.4	17.8
Balance at beginning of period	125.4	130.7
Balance at end of period	140.8	148.5
Reportable Legal Entities | Parent
Cash flows from operating activities
Net cash (used in) provided by operating activities	(42.5)	(69.7)
Cash flows from investing activities
Capital expenditures	(0.6)	0
Intercompany investment	0	0
Other		(3.9)
Net cash used in investing activities	(0.6)	(3.9)
Cash flows from financing activities
Proceeds from long-term debt	58	128
Repayments on long-term debt and finance leases	(21)	(23)
Exercises of stock options	0.5	1.1
Payments on tax withholdings for equity awards	(0.1)	(0.7)
Intercompany financing	7.1	(0.5)
Net cash provided by financing activities	44.5	104.9
Effect of exchange rate changes on cash	0	0
Net increase in cash and cash equivalents and restricted cash	1.4	31.3
Balance at beginning of period	8.6	10.7
Balance at end of period	10	42
Reportable Legal Entities | Guarantor Subsidiaries
Cash flows from operating activities
Net cash (used in) provided by operating activities	(14.8)	(4.5)
Cash flows from investing activities
Capital expenditures	(1.4)	(4.5)
Intercompany investment	19.9	7.6
Other		0
Net cash used in investing activities	18.5	3.1
Cash flows from financing activities
Proceeds from long-term debt	0	0
Repayments on long-term debt and finance leases	(0.1)	(0.2)
Exercises of stock options	0	0
Payments on tax withholdings for equity awards	0	0
Intercompany financing	0	0
Net cash provided by financing activities	(0.1)	(0.2)
Effect of exchange rate changes on cash	0	0
Net increase in cash and cash equivalents and restricted cash	3.6	(1.6)
Balance at beginning of period	0	0.7
Balance at end of period	3.6	(0.9)
Reportable Legal Entities | Non- Guarantor Subsidiaries
Cash flows from operating activities
Net cash (used in) provided by operating activities	40.7	1.7
Cash flows from investing activities
Capital expenditures	(2.7)	(1.1)
Intercompany investment	(27)	(7.1)
Other		0
Net cash used in investing activities	(29.7)	(8.2)
Cash flows from financing activities
Proceeds from long-term debt	0	0
Repayments on long-term debt and finance leases	(0.2)	(0.1)
Exercises of stock options	0	0
Payments on tax withholdings for equity awards	0	0
Intercompany financing	0	0
Net cash provided by financing activities	(0.2)	(0.1)
Effect of exchange rate changes on cash	(0.6)	(5.3)
Net increase in cash and cash equivalents and restricted cash	10.2	(11.9)
Balance at beginning of period	117	119.3
Balance at end of period	127.2	107.4
Consolidating Adjustments
Cash flows from operating activities
Net cash (used in) provided by operating activities	0.2	0
Cash flows from investing activities
Capital expenditures	0	0
Intercompany investment	7.1	(0.5)
Other		0
Net cash used in investing activities	7.1	(0.5)
Cash flows from financing activities
Proceeds from long-term debt	0	0
Repayments on long-term debt and finance leases	0	0
Exercises of stock options	0	0
Payments on tax withholdings for equity awards	0	0
Intercompany financing	(7.1)	0.5
Net cash provided by financing activities	(7.1)	0.5
Effect of exchange rate changes on cash	0	0
Net increase in cash and cash equivalents and restricted cash	0.2	0
Balance at beginning of period	(0.2)	0
Balance at end of period	$ 0	$ 0

Subsequent Event (Details)

Subsequent Event (Details) - $ / shares	Apr. 20, 2021	Mar. 31, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01
Subsequent Event
Subsequent Event [Line Items]
Share capital acquired (as a percent)	24.00%
Subsequent Event | The Middleby Corporation
Subsequent Event [Line Items]
Share capital acquired (as a percent)	76.00%
Subsequent Event | The Middleby Corporation
Subsequent Event [Line Items]
Number of shares issued per acquiree share	0.1240

Uncategorized Items - wbt-20210

Label	Element	Value
Accounting Standards Update [Extensible List]	us-gaap_AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member